
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            BRCA1 and BRCA2 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B37B192646AC33C37B1003D8018BB.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6282814/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Human Mutation">
<meta name="citation_title" content="BRCA1 and BRCA2 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding">
<meta name="citation_author" content="Leslie J Burke">
<meta name="citation_author_institution" content="School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia">
<meta name="citation_author" content="Jan Sevcik">
<meta name="citation_author_institution" content="School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia">
<meta name="citation_author_institution" content="Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic">
<meta name="citation_author" content="Gaetana Gambino">
<meta name="citation_author_institution" content="School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia">
<meta name="citation_author_institution" content="Section of Molecular Genetics, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy">
<meta name="citation_author" content="Emma Tudini">
<meta name="citation_author_institution" content="School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia">
<meta name="citation_author_institution" content="Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia">
<meta name="citation_author" content="Eliseos J Mucaki">
<meta name="citation_author_institution" content="University of Western Ontario, Department of Biochemistry, Schulich School of Medicine and Dentistry, London, Ontario, Canada">
<meta name="citation_author" content="Ben C Shirley">
<meta name="citation_author_institution" content="CytoGnomix Inc. London, Ontario, Canada">
<meta name="citation_author" content="Phillip Whiley">
<meta name="citation_author_institution" content="School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia">
<meta name="citation_author_institution" content="Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia">
<meta name="citation_author" content="Michael T Parsons">
<meta name="citation_author_institution" content="Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia">
<meta name="citation_author" content="Kim De Leeneer">
<meta name="citation_author_institution" content="Center for Medical Genetics, Ghent University Hospital, and Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium">
<meta name="citation_author" content="Sara Gutiérrez‐Enríquez">
<meta name="citation_author_institution" content="Oncogenetics Group, Vall d&#x27;Hebron Institute of Oncology (VHIO), Barcelona, Spain">
<meta name="citation_author" content="Marta Santamariña">
<meta name="citation_author_institution" content="Fundación Pública Galega de Medicina Xenómica‐SERGAS, Grupo de Medicina Xenómica‐USC, CIBERER, IDIS, Santiago de Compostela, Spain">
<meta name="citation_author" content="Sandrine M Caputo">
<meta name="citation_author_institution" content="Service de Génétique, Department de Biologie des Tumeurs, Institut Curie, Paris, France">
<meta name="citation_author" content="Elizabeth Santana dos Santos">
<meta name="citation_author_institution" content="Service de Génétique, Department de Biologie des Tumeurs, Institut Curie, Paris, France">
<meta name="citation_author_institution" content="Department of oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo ‐ ICESP, São Paulo, Brazil">
<meta name="citation_author_institution" content="A.C.Camargo Cancer Center, São Paulo, Brazil">
<meta name="citation_author" content="Jana Soukupova">
<meta name="citation_author_institution" content="Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic">
<meta name="citation_author" content="Marketa Janatova">
<meta name="citation_author_institution" content="Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic">
<meta name="citation_author" content="Petra Zemankova">
<meta name="citation_author_institution" content="Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic">
<meta name="citation_author" content="Klara Lhotova">
<meta name="citation_author_institution" content="Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic">
<meta name="citation_author" content="Lenka Stolarova">
<meta name="citation_author_institution" content="Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic">
<meta name="citation_author" content="Mariana Borecka">
<meta name="citation_author_institution" content="Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic">
<meta name="citation_author" content="Alejandro Moles‐Fernández">
<meta name="citation_author_institution" content="Oncogenetics Group, Vall d&#x27;Hebron Institute of Oncology (VHIO), Barcelona, Spain">
<meta name="citation_author" content="Siranoush Manoukian">
<meta name="citation_author_institution" content="Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy">
<meta name="citation_author" content="Bernardo Bonanni">
<meta name="citation_author_institution" content="Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy">
<meta name="citation_author" content="ENIGMA Consortium">
<meta name="citation_author_institution" content="School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia">
<meta name="citation_author" content="Stacey L Edwards">
<meta name="citation_author_institution" content="Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia">
<meta name="citation_author" content="Marinus J Blok">
<meta name="citation_author_institution" content="Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands">
<meta name="citation_author" content="Thomas van Overeem Hansen">
<meta name="citation_author_institution" content="Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark">
<meta name="citation_author" content="Maria Rossing">
<meta name="citation_author_institution" content="Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark">
<meta name="citation_author" content="Orland Diez">
<meta name="citation_author_institution" content="Oncogenetics Group, Vall d&#x27;Hebron Institute of Oncology (VHIO), Barcelona, Spain">
<meta name="citation_author_institution" content="Area of Clinical and Molecular Genetics, University Hospital Vall d&#x27;Hebron (UHVH), Barcelona, Spain">
<meta name="citation_author" content="Ana Vega">
<meta name="citation_author_institution" content="Fundación Pública Galega de Medicina Xenómica‐SERGAS, Grupo de Medicina Xenómica‐USC, CIBERER, IDIS, Santiago de Compostela, Spain">
<meta name="citation_author" content="Kathleen BM Claes">
<meta name="citation_author_institution" content="Center for Medical Genetics, Ghent University Hospital, and Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium">
<meta name="citation_author" content="David E Goldgar">
<meta name="citation_author_institution" content="Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah">
<meta name="citation_author" content="Etienne Rouleau">
<meta name="citation_author_institution" content="Gustave Roussy, Villejuif, France">
<meta name="citation_author" content="Paolo Radice">
<meta name="citation_author_institution" content="Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy">
<meta name="citation_author" content="Paolo Peterlongo">
<meta name="citation_author_institution" content="IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy">
<meta name="citation_author" content="Peter K Rogan">
<meta name="citation_author_institution" content="University of Western Ontario, Department of Biochemistry, Schulich School of Medicine and Dentistry, London, Ontario, Canada">
<meta name="citation_author_institution" content="CytoGnomix Inc. London, Ontario, Canada">
<meta name="citation_author" content="Maria Caligo">
<meta name="citation_author_institution" content="Section of Molecular Genetics, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy">
<meta name="citation_author" content="Amanda B Spurdle">
<meta name="citation_author_institution" content="Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia">
<meta name="citation_author" content="Melissa A Brown">
<meta name="citation_author_institution" content="School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia">
<meta name="citation_publication_date" content="2018 Sep 24">
<meta name="citation_volume" content="39">
<meta name="citation_issue" content="12">
<meta name="citation_firstpage" content="2025">
<meta name="citation_doi" content="10.1002/humu.23652">
<meta name="citation_pmid" content="30204945">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6282814/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6282814/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6282814/pdf/HUMU-39-2025.pdf">
<meta name="description" content="The widespread use of next generation sequencing for clinical testing is detecting an escalating number of variants in noncoding regions of the genome. The clinical significance of the majority of these variants is currently unknown, which presents ...">
<meta name="og:title" content="BRCA1 and BRCA2 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The widespread use of next generation sequencing for clinical testing is detecting an escalating number of variants in noncoding regions of the genome. The clinical significance of the majority of these variants is currently unknown, which presents ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC6282814/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="6282814">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1002/humu.23652"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/HUMU-39-2025.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC6282814%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/6282814/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/6282814/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC6282814/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1002/humu.23652" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Hum Mutat</button></div>. 2018 Sep 24;39(12):2025–2039. doi: <a href="https://doi.org/10.1002/humu.23652" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/humu.23652</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Hum%20Mutat%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hum%20Mutat%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Hum%20Mutat%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Hum%20Mutat%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>
<em>BRCA1</em> and <em>BRCA2</em> 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Burke%20LJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Leslie J Burke</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Leslie J Burke</span></h3>
<div class="p">
<sup><sup>1</sup></sup>School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Burke%20LJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Leslie J Burke</span></a>
</div>
</div>
<sup>1,</sup><sup>†,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sevcik%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Jan Sevcik</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Jan Sevcik</span></h3>
<div class="p">
<sup><sup>1</sup></sup>School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia</div>
<div class="p">
<sup><sup>2</sup></sup>Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sevcik%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jan Sevcik</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gambino%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Gaetana Gambino</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Gaetana Gambino</span></h3>
<div class="p">
<sup><sup>1</sup></sup>School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia</div>
<div class="p">
<sup><sup>3</sup></sup>Section of Molecular Genetics, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gambino%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gaetana Gambino</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tudini%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Emma Tudini</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Emma Tudini</span></h3>
<div class="p">
<sup><sup>1</sup></sup>School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia</div>
<div class="p">
<sup><sup>4</sup></sup>Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tudini%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Emma Tudini</span></a>
</div>
</div>
<sup>1,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mucaki%20EJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Eliseos J Mucaki</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Eliseos J Mucaki</span></h3>
<div class="p">
<sup><sup>5</sup></sup>University of Western Ontario, Department of Biochemistry, Schulich School of Medicine and Dentistry, London, Ontario, Canada</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mucaki%20EJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Eliseos J Mucaki</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shirley%20BC%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Ben C Shirley</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Ben C Shirley</span></h3>
<div class="p">
<sup><sup>6</sup></sup>CytoGnomix Inc. London, Ontario, Canada</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shirley%20BC%22%5BAuthor%5D" class="usa-link"><span class="name western">Ben C Shirley</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Whiley%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Phillip Whiley</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Phillip Whiley</span></h3>
<div class="p">
<sup><sup>1</sup></sup>School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia</div>
<div class="p">
<sup><sup>4</sup></sup>Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Whiley%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Phillip Whiley</span></a>
</div>
</div>
<sup>1,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Parsons%20MT%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Michael T Parsons</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Michael T Parsons</span></h3>
<div class="p">
<sup><sup>4</sup></sup>Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Parsons%20MT%22%5BAuthor%5D" class="usa-link"><span class="name western">Michael T Parsons</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22De%20Leeneer%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Kim De Leeneer</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Kim De Leeneer</span></h3>
<div class="p">
<sup><sup>7</sup></sup>Center for Medical Genetics, Ghent University Hospital, and Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22De%20Leeneer%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kim De Leeneer</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guti%C3%A9rrez%E2%80%90Enr%C3%ADquez%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Sara Gutiérrez‐Enríquez</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Sara Gutiérrez‐Enríquez</span></h3>
<div class="p">
<sup><sup>8</sup></sup>Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guti%C3%A9rrez%E2%80%90Enr%C3%ADquez%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sara Gutiérrez‐Enríquez</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Santamari%C3%B1a%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Marta Santamariña</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Marta Santamariña</span></h3>
<div class="p">
<sup><sup>9</sup></sup>Fundación Pública Galega de Medicina Xenómica‐SERGAS, Grupo de Medicina Xenómica‐USC, CIBERER, IDIS, Santiago de Compostela, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Santamari%C3%B1a%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marta Santamariña</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caputo%20SM%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Sandrine M Caputo</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Sandrine M Caputo</span></h3>
<div class="p">
<sup><sup>10</sup></sup>Service de Génétique, Department de Biologie des Tumeurs, Institut Curie, Paris, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caputo%20SM%22%5BAuthor%5D" class="usa-link"><span class="name western">Sandrine M Caputo</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Santana%20dos%20Santos%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Elizabeth Santana dos Santos</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Elizabeth Santana dos Santos</span></h3>
<div class="p">
<sup><sup>10</sup></sup>Service de Génétique, Department de Biologie des Tumeurs, Institut Curie, Paris, France</div>
<div class="p">
<sup><sup>11</sup></sup>Department of oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo ‐ ICESP, São Paulo, Brazil</div>
<div class="p">
<sup><sup>12</sup></sup>A.C.Camargo Cancer Center, São Paulo, Brazil</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Santana%20dos%20Santos%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elizabeth Santana dos Santos</span></a>
</div>
</div>
<sup>10,</sup><sup>11,</sup><sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soukupova%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Jana Soukupova</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Jana Soukupova</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soukupova%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jana Soukupova</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Janatova%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Marketa Janatova</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Marketa Janatova</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Janatova%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marketa Janatova</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zemankova%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Petra Zemankova</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Petra Zemankova</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zemankova%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Petra Zemankova</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lhotova%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Klara Lhotova</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Klara Lhotova</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lhotova%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Klara Lhotova</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stolarova%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Lenka Stolarova</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Lenka Stolarova</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stolarova%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lenka Stolarova</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Borecka%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Mariana Borecka</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Mariana Borecka</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Borecka%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mariana Borecka</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Moles%E2%80%90Fern%C3%A1ndez%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Alejandro Moles‐Fernández</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Alejandro Moles‐Fernández</span></h3>
<div class="p">
<sup><sup>8</sup></sup>Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Moles%E2%80%90Fern%C3%A1ndez%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alejandro Moles‐Fernández</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Manoukian%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Siranoush Manoukian</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Siranoush Manoukian</span></h3>
<div class="p">
<sup><sup>13</sup></sup>Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Manoukian%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Siranoush Manoukian</span></a>
</div>
</div>
<sup>13</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bonanni%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Bernardo Bonanni</span></a><div hidden="hidden" id="id22">
<h3><span class="name western">Bernardo Bonanni</span></h3>
<div class="p">
<sup><sup>14</sup></sup>Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bonanni%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Bernardo Bonanni</span></a>
</div>
</div>
<sup>14</sup>; <span class="collab">ENIGMA Consortium</span><sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Edwards%20SL%22%5BAuthor%5D" class="usa-link" aria-describedby="id23"><span class="name western">Stacey L Edwards</span></a><div hidden="hidden" id="id23">
<h3><span class="name western">Stacey L Edwards</span></h3>
<div class="p">
<sup><sup>4</sup></sup>Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Edwards%20SL%22%5BAuthor%5D" class="usa-link"><span class="name western">Stacey L Edwards</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Blok%20MJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id24"><span class="name western">Marinus J Blok</span></a><div hidden="hidden" id="id24">
<h3><span class="name western">Marinus J Blok</span></h3>
<div class="p">
<sup><sup>15</sup></sup>Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Blok%20MJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Marinus J Blok</span></a>
</div>
</div>
<sup>15</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20Overeem%20Hansen%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id25"><span class="name western">Thomas van Overeem Hansen</span></a><div hidden="hidden" id="id25">
<h3><span class="name western">Thomas van Overeem Hansen</span></h3>
<div class="p">
<sup><sup>16</sup></sup>Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20Overeem%20Hansen%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Thomas van Overeem Hansen</span></a>
</div>
</div>
<sup>16</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rossing%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id26"><span class="name western">Maria Rossing</span></a><div hidden="hidden" id="id26">
<h3><span class="name western">Maria Rossing</span></h3>
<div class="p">
<sup><sup>16</sup></sup>Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rossing%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maria Rossing</span></a>
</div>
</div>
<sup>16</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Diez%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id27"><span class="name western">Orland Diez</span></a><div hidden="hidden" id="id27">
<h3><span class="name western">Orland Diez</span></h3>
<div class="p">
<sup><sup>8</sup></sup>Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain</div>
<div class="p">
<sup><sup>17</sup></sup>Area of Clinical and Molecular Genetics, University Hospital Vall d'Hebron (UHVH), Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Diez%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Orland Diez</span></a>
</div>
</div>
<sup>8,</sup><sup>17</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vega%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id28"><span class="name western">Ana Vega</span></a><div hidden="hidden" id="id28">
<h3><span class="name western">Ana Vega</span></h3>
<div class="p">
<sup><sup>9</sup></sup>Fundación Pública Galega de Medicina Xenómica‐SERGAS, Grupo de Medicina Xenómica‐USC, CIBERER, IDIS, Santiago de Compostela, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vega%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ana Vega</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Claes%20KBM%22%5BAuthor%5D" class="usa-link" aria-describedby="id29"><span class="name western">Kathleen BM Claes</span></a><div hidden="hidden" id="id29">
<h3><span class="name western">Kathleen BM Claes</span></h3>
<div class="p">
<sup><sup>7</sup></sup>Center for Medical Genetics, Ghent University Hospital, and Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Claes%20KBM%22%5BAuthor%5D" class="usa-link"><span class="name western">Kathleen BM Claes</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Goldgar%20DE%22%5BAuthor%5D" class="usa-link" aria-describedby="id30"><span class="name western">David E Goldgar</span></a><div hidden="hidden" id="id30">
<h3><span class="name western">David E Goldgar</span></h3>
<div class="p">
<sup><sup>18</sup></sup>Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Goldgar%20DE%22%5BAuthor%5D" class="usa-link"><span class="name western">David E Goldgar</span></a>
</div>
</div>
<sup>18</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rouleau%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id31"><span class="name western">Etienne Rouleau</span></a><div hidden="hidden" id="id31">
<h3><span class="name western">Etienne Rouleau</span></h3>
<div class="p">
<sup><sup>19</sup></sup>Gustave Roussy, Villejuif, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rouleau%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Etienne Rouleau</span></a>
</div>
</div>
<sup>19</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Radice%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id32"><span class="name western">Paolo Radice</span></a><div hidden="hidden" id="id32">
<h3><span class="name western">Paolo Radice</span></h3>
<div class="p">
<sup><sup>20</sup></sup>Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Radice%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Paolo Radice</span></a>
</div>
</div>
<sup>20</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peterlongo%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id33"><span class="name western">Paolo Peterlongo</span></a><div hidden="hidden" id="id33">
<h3><span class="name western">Paolo Peterlongo</span></h3>
<div class="p">
<sup><sup>21</sup></sup>IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peterlongo%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Paolo Peterlongo</span></a>
</div>
</div>
<sup>21</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rogan%20PK%22%5BAuthor%5D" class="usa-link" aria-describedby="id34"><span class="name western">Peter K Rogan</span></a><div hidden="hidden" id="id34">
<h3><span class="name western">Peter K Rogan</span></h3>
<div class="p">
<sup><sup>5</sup></sup>University of Western Ontario, Department of Biochemistry, Schulich School of Medicine and Dentistry, London, Ontario, Canada</div>
<div class="p">
<sup><sup>6</sup></sup>CytoGnomix Inc. London, Ontario, Canada</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rogan%20PK%22%5BAuthor%5D" class="usa-link"><span class="name western">Peter K Rogan</span></a>
</div>
</div>
<sup>5,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caligo%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id35"><span class="name western">Maria Caligo</span></a><div hidden="hidden" id="id35">
<h3><span class="name western">Maria Caligo</span></h3>
<div class="p">
<sup><sup>3</sup></sup>Section of Molecular Genetics, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caligo%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maria Caligo</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Spurdle%20AB%22%5BAuthor%5D" class="usa-link" aria-describedby="id36"><span class="name western">Amanda B Spurdle</span></a><div hidden="hidden" id="id36">
<h3><span class="name western">Amanda B Spurdle</span></h3>
<div class="p">
<sup><sup>4</sup></sup>Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Spurdle%20AB%22%5BAuthor%5D" class="usa-link"><span class="name western">Amanda B Spurdle</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Brown%20MA%22%5BAuthor%5D" class="usa-link" aria-describedby="id37"><span class="name western">Melissa A Brown</span></a><div hidden="hidden" id="id37">
<h3><span class="name western">Melissa A Brown</span></h3>
<div class="p">
<sup><sup>1</sup></sup>School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Brown%20MA%22%5BAuthor%5D" class="usa-link"><span class="name western">Melissa A Brown</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="humu23652-aff-0001">
<sup><sup>1</sup></sup>School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia</div>
<div id="humu23652-aff-0002">
<sup><sup>2</sup></sup>Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic</div>
<div id="humu23652-aff-0003">
<sup><sup>3</sup></sup>Section of Molecular Genetics, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy</div>
<div id="humu23652-aff-0004">
<sup><sup>4</sup></sup>Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia</div>
<div id="humu23652-aff-0005">
<sup><sup>5</sup></sup>University of Western Ontario, Department of Biochemistry, Schulich School of Medicine and Dentistry, London, Ontario, Canada</div>
<div id="humu23652-aff-0006">
<sup><sup>6</sup></sup>CytoGnomix Inc. London, Ontario, Canada</div>
<div id="humu23652-aff-0007">
<sup><sup>7</sup></sup>Center for Medical Genetics, Ghent University Hospital, and Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium</div>
<div id="humu23652-aff-0008">
<sup><sup>8</sup></sup>Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain</div>
<div id="humu23652-aff-0009">
<sup><sup>9</sup></sup>Fundación Pública Galega de Medicina Xenómica‐SERGAS, Grupo de Medicina Xenómica‐USC, CIBERER, IDIS, Santiago de Compostela, Spain</div>
<div id="humu23652-aff-0010">
<sup><sup>10</sup></sup>Service de Génétique, Department de Biologie des Tumeurs, Institut Curie, Paris, France</div>
<div id="humu23652-aff-0011">
<sup><sup>11</sup></sup>Department of oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo ‐ ICESP, São Paulo, Brazil</div>
<div id="humu23652-aff-0012">
<sup><sup>12</sup></sup>A.C.Camargo Cancer Center, São Paulo, Brazil</div>
<div id="humu23652-aff-0013">
<sup><sup>13</sup></sup>Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy</div>
<div id="humu23652-aff-0014">
<sup><sup>14</sup></sup>Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy</div>
<div id="humu23652-aff-0015">
<sup><sup>15</sup></sup>Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands</div>
<div id="humu23652-aff-0016">
<sup><sup>16</sup></sup>Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark</div>
<div id="humu23652-aff-0017">
<sup><sup>17</sup></sup>Area of Clinical and Molecular Genetics, University Hospital Vall d'Hebron (UHVH), Barcelona, Spain</div>
<div id="humu23652-aff-0018">
<sup><sup>18</sup></sup>Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah</div>
<div id="humu23652-aff-0019">
<sup><sup>19</sup></sup>Gustave Roussy, Villejuif, France</div>
<div id="humu23652-aff-0020">
<sup><sup>20</sup></sup>Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy</div>
<div id="humu23652-aff-0021">
<sup><sup>21</sup></sup>IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline"><strong>Correspondence</strong>, Leslie J. Burke, School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia. Email: <span>l.burke@uq.edu.au</span></p>
</div>
<div class="fn" id="humu23652-note-0001">
<sup>†</sup><p class="display-inline">These authors contributed equally to this study and are shared first authors.</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2018 Apr 16; Revised 2018 Sep 1; Accepted 2018 Sep 7; Issue date 2018 Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2018 The Authors. <em>Human Mutation</em> published by Wiley Periodicals, Inc.</div>
<p>This is an open access article under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC6282814  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30204945/" class="usa-link">30204945</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>The widespread use of next generation sequencing for clinical testing is detecting an escalating number of variants in noncoding regions of the genome. The clinical significance of the majority of these variants is currently unknown, which presents a significant clinical challenge. We have screened over 6,000 early‐onset and/or familial breast cancer (BC) cases collected by the ENIGMA consortium for sequence variants in the 5′ noncoding regions of BC susceptibility genes <em>BRCA1</em> and <em>BRCA2</em>, and identified 141 rare variants with global minor allele frequency &lt; 0.01, 76 of which have not been reported previously. Bioinformatic analysis identified a set of 21 variants most likely to impact transcriptional regulation, and luciferase reporter assays detected altered promoter activity for four of these variants. Electrophoretic mobility shift assays demonstrated that three of these altered the binding of proteins to the respective <em>BRCA1</em> or <em>BRCA2</em> promoter regions, including NFYA binding to <em>BRCA1</em>:c.‐287C&gt;T and PAX5 binding to <em>BRCA2</em>:c.‐296C&gt;T. Clinical classification of variants affecting promoter activity, using existing prediction models, found no evidence to suggest that these variants confer a high risk of disease. Further studies are required to determine if such variation may be associated with a moderate or low risk of BC.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> breast cancer, BRCA1, BRCA2, promoter, transcription, variants of unknown clinical significance (VUS)</p></section></section><section id="humu23652-sec-0010"><h2 class="pmc_sec_title">1. INTRODUCTION</h2>
<p>Genetic susceptibility to breast cancer (BC) is complex. Multiple germline variants have been identified over the past 25 years that are broadly categorized as high, moderate, and low risk. High‐risk variants are generally rare, have a major deleterious effect on gene function, are sufficient to confer a high risk of disease, and are highly penetrant within a family. Nonsense, splicing, large deletions, and some missense changes in <em>BRCA1</em> and <em>BRCA2</em> fall into this category (reviewed in Walsh et al., <a href="#humu23652-bib-0057" class="usa-link" aria-describedby="humu23652-bib-0057">2006</a>). There is also evidence that some alleles confer a moderate risk of cancer. These can include hypomorphic variants in known “high‐risk” cancer syndrome genes (Shimelis et al., <a href="#humu23652-bib-0047" class="usa-link" aria-describedby="humu23652-bib-0047">2017</a>; Spurdle et al., <a href="#humu23652-bib-0050" class="usa-link" aria-describedby="humu23652-bib-0050">2012</a>), or clear loss‐of‐function alleles in other genes such as <em>CHEK2</em>, <em>PALB2</em>, and <em>ATM</em> (Couch et al., <a href="#humu23652-bib-0010" class="usa-link" aria-describedby="humu23652-bib-0010">2017</a>). Low‐risk variants, largely identified by genome‐wide association studies, are usually common and cause subtle functional effects, such as small but significant changes in gene expression due to altered activity of proximal and distal regulatory elements (reviewed in Bogdanova, Helbig, &amp; Dork, <a href="#humu23652-bib-0006" class="usa-link" aria-describedby="humu23652-bib-0006">2013</a>; Ghoussaini, Pharoah, &amp; Easton, <a href="#humu23652-bib-0019" class="usa-link" aria-describedby="humu23652-bib-0019">2013</a>; Skol, Sasaki, &amp; Onel, <a href="#humu23652-bib-0048" class="usa-link" aria-describedby="humu23652-bib-0048">2016</a>). Evidence suggests that combinations of low, moderate, and high‐risk variants could confer a clinically significant risk of disease (Ding et al., <a href="#humu23652-bib-0014" class="usa-link" aria-describedby="humu23652-bib-0014">2012</a>; Kuchenbaecker et al., <a href="#humu23652-bib-0027" class="usa-link" aria-describedby="humu23652-bib-0027">2017</a>; Sawyer et al., <a href="#humu23652-bib-0046" class="usa-link" aria-describedby="humu23652-bib-0046">2012</a>). Identification and evaluation of all such variants is therefore crucial for accurately predicting BC risk.</p>
<p>Use of next generation sequence analysis for germline clinical testing of cancer cases is identifying an increasing number of variants in noncoding regions of cancer susceptibility genes, including promoters, untranslated regions (UTRs), and introns. There are currently no firm recommendations for assessing the relevance of noncoding region variants to clinical testing of Mendelian disease genes, and so the vast majority of such variants are deemed of uncertain clinical significance. This adds to the clinical challenge presented by variants of uncertain significance, namely that they complicate test reporting and genetic counseling, limit patient eligibility for intensive surveillance and gene‐targeted therapies, and prevent gene testing and guided management of relatives (reviewed in Amendola et al., <a href="#humu23652-bib-0001" class="usa-link" aria-describedby="humu23652-bib-0001">2015</a>; Eccles et al., <a href="#humu23652-bib-0015" class="usa-link" aria-describedby="humu23652-bib-0015">2013</a>; Plon et al., <a href="#humu23652-bib-0040" class="usa-link" aria-describedby="humu23652-bib-0040">2011</a>). It is therefore essential that the functional and clinical significance of variants mapping to noncoding regions of the genome is determined.</p>
<p>Gene expression is controlled at many levels with key regulatory elements being housed in noncoding regions of the genome, such as gene promoters, introns, long‐range elements, and 5′ and 3′ UTRs. The <em>BRCA1</em> gene is regulated at the transcriptional and posttranscriptional levels, with functional proximal and distal regulatory elements being described in the promoter, introns, and UTRs, by us and others (Brewster et al., <a href="#humu23652-bib-0007" class="usa-link" aria-describedby="humu23652-bib-0007">2012</a>; Brown et al., <a href="#humu23652-bib-0008" class="usa-link" aria-describedby="humu23652-bib-0008">2002</a>; Santana dos Santos et al., <a href="#humu23652-bib-0044" class="usa-link" aria-describedby="humu23652-bib-0044">2017</a>; Saunus et al., <a href="#humu23652-bib-0045" class="usa-link" aria-describedby="humu23652-bib-0045">2008</a>; Tan‐Wong, French, Proudfoot, &amp; Brown, <a href="#humu23652-bib-0054" class="usa-link" aria-describedby="humu23652-bib-0054">2008</a>; Wardrop, Brown, &amp; kConFab, <a href="#humu23652-bib-0058" class="usa-link" aria-describedby="humu23652-bib-0058">2005</a>; Wiedemeyer, Beach, &amp; Karlan, <a href="#humu23652-bib-0059" class="usa-link" aria-describedby="humu23652-bib-0059">2014</a>). Although less studied, the <em>BRCA2</em> promoter has also been mapped and characterized (reviewed in Wiedemeyer et al., <a href="#humu23652-bib-0059" class="usa-link" aria-describedby="humu23652-bib-0059">2014</a>).</p>
<p>Common and rare variations in regulatory elements upstream of genes have been shown to alter gene expression and be associated with disease risk (reviewed in Betts, French, Brown, &amp; Edwards, <a href="#humu23652-bib-0004" class="usa-link" aria-describedby="humu23652-bib-0004">2013</a>; Diederichs et al., <a href="#humu23652-bib-0013" class="usa-link" aria-describedby="humu23652-bib-0013">2016</a>; Millot et al., <a href="#humu23652-bib-0033" class="usa-link" aria-describedby="humu23652-bib-0033">2012</a>). We and others have described germline cancer‐associated variants in the regulatory regions, including large deletions in the <em>BRCA1</em> promoter (Brown et al., <a href="#humu23652-bib-0008" class="usa-link" aria-describedby="humu23652-bib-0008">2002</a>), and single nucleotide variants in the promoter and/or 5′ UTR of <em>BRCA1</em> and <em>BRCA2</em> (Evans et al., <a href="#humu23652-bib-0016" class="usa-link" aria-describedby="humu23652-bib-0016">2018</a>; Santana dos Santos et al., <a href="#humu23652-bib-0044" class="usa-link" aria-describedby="humu23652-bib-0044">2017</a>), <em>MLH1</em> promoter (Hitchins et al., <a href="#humu23652-bib-0023" class="usa-link" aria-describedby="humu23652-bib-0023">2011</a>), <em>POLG</em> promoter (Popanda et al., <a href="#humu23652-bib-0041" class="usa-link" aria-describedby="humu23652-bib-0041">2013</a>), <em>PTEN</em> promoter (Heikkinen et al., <a href="#humu23652-bib-0022" class="usa-link" aria-describedby="humu23652-bib-0022">2011</a>), <em>TERT</em> promoter (Horn et al., <a href="#humu23652-bib-0024" class="usa-link" aria-describedby="humu23652-bib-0024">2013</a>), <em>KLHDC7A</em> and <em>PIDD1</em> promoters (Michailidou et al., <a href="#humu23652-bib-0032" class="usa-link" aria-describedby="humu23652-bib-0032">2017</a>), <em>BRCA1</em> 3′ UTR (Brewster et al., <a href="#humu23652-bib-0007" class="usa-link" aria-describedby="humu23652-bib-0007">2012</a>), and BC‐associated Single Nucleotide Polymorphisms (SNPs) in long‐range enhancers of <em>CCND1</em> (French et al., <a href="#humu23652-bib-0018" class="usa-link" aria-describedby="humu23652-bib-0018">2013</a>).</p>
<p>Cancer risk‐associated variants within regulatory regions are anticipated to mediate an effect on trans‐acting regulatory factors (e.g., transcription factors [TFs] and miRNAs), by disrupting binding of regulatory factors and interactions between regulatory elements, such as promoter–enhancer interactions. For example, a variant in a <em>Cyclin D1</em> transcriptional enhancer has been associated with altered binding of the ELK4 TF (French et al., <a href="#humu23652-bib-0018" class="usa-link" aria-describedby="humu23652-bib-0018">2013</a>) and a variant within the <em>BRCA1</em> 3′UTR has been shown to introduce a functional mir‐103 binding site (Brewster et al., <a href="#humu23652-bib-0007" class="usa-link" aria-describedby="humu23652-bib-0007">2012</a>). In addition, a dominantly inherited 5′ UTR <em>BRCA1</em> variant was recently shown to be associated with <em>BRCA1</em> promoter hypermethylation, which is known to impact TF binding, and associated allelic loss of <em>BRCA1</em> expression in two families affected by breast and ovarian cancers (Evans et al., <a href="#humu23652-bib-0016" class="usa-link" aria-describedby="humu23652-bib-0016">2018</a>).</p>
<p>In this paper, we describe 141 germline variants in the <em>BRCA1</em> and <em>BRCA2</em> promoter, identified by members of the ENIGMA consortium in early onset or familial BC patients with no known pathogenic variants in the coding region of these genes. Using a combination of bioinformatic and experimental analyses, we have prioritized and analyzed a subset of variants that are most likely to affect the regulation of <em>BRCA1</em> and <em>BRCA2</em> and thus have the most potential to contribute to BC risk. TF binding site affinity changes resulting from these variants were subsequently analyzed by information theory (IT)‐based analyses. In parallel, we have assessed if these variants exhibited the features expected for a high‐risk pathogenic <em>BRCA1</em> or <em>BRCA2</em> variant, on the basis of available clinical and population data.</p></section><section id="humu23652-sec-0020"><h2 class="pmc_sec_title">2. MATERIALS AND METHODS</h2>
<section id="humu23652-sec-0030"><h3 class="pmc_sec_title">2.1. Study design</h3>
<p>An overview of the study design is shown in Figure <a href="#humu23652-fig-0001" class="usa-link">1</a>. Collection of variants at all sites enabled an initial catalogue of variants from which variants were prioritized for functional analysis. Additional screening was carried out at three sites, Maastricht (M), Santiago (S), and Prague (Pr), that included additional patients (M, S, and Pr) and controls (Pr) that expanded the list of variants (Pr), the number of patients (M, S, and Pr), and included control subjects (Pr).</p>
<figure class="fig xbox font-sm" id="humu23652-fig-0001" lang="en"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c15/6282814/19f8c468468a/HUMU-39-2025-g001.jpg" loading="lazy" id="nlm-graphic-3" height="976" width="760" alt="Figure 1"></p>
<div class="p text-right font-secondary"><a href="figure/humu23652-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Overview of study design. Outline of the workflow of variant collection, prioritization and analysis</p></figcaption></figure></section><section id="humu23652-sec-0040"><h3 class="pmc_sec_title">2.2. Clinical and control samples</h3>
<p>Clinical and genetic data were collected and analyzed in accordance with local human ethics guidelines of the institutions contributing to this study. All participating individuals provided informed consent for their data to be used for research purposes. An overview of the samples analyzed is shown in Table <a href="#humu23652-tbl-0001" class="usa-link">1</a>. Clinical samples were collected from nine European sites and were originally selected for <em>BRCA1</em> and <em>BRCA2</em> testing using ascertainment criteria that included family history and young age of BC diagnosis. Female patients who did not carry a pathogenic variant in <em>BRCA1</em> or <em>BRCA2</em> coding regions or splice junctions were selected for testing of variation in the <em>BRCA1</em> and <em>BRCA2</em> 5′ regions. The controls were as follows: 661 healthy female individuals recruited through the Immunohematology and Transfusion Medicine Service of INT and Associazione Volontari Italiani Sangue (AVIS) of Milan; 312 healthy females above 60 years of age and with no malignancy in the first filial generation recruited through First Faculty of Medicine, Charles University in Prague (Lhota et al., <a href="#humu23652-bib-0028" class="usa-link" aria-describedby="humu23652-bib-0028">2016</a>; Soukupova, Zemankova, Kleiblova, Janatova, &amp; Kleibl, <a href="#humu23652-bib-0049" class="usa-link" aria-describedby="humu23652-bib-0049">2016</a>); and 130 healthy females without cancer diagnosis recruited in Santiago de Compostela.</p>
<section class="tw xbox font-sm" id="humu23652-tbl-0001" lang="en"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Samples used in this study</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<thead><tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="1" colspan="1">Location</th>
<th align="left" rowspan="1" colspan="1">Institution</th>
<th align="left" rowspan="1" colspan="1">Samples</th>
<th align="left" rowspan="1" colspan="1">Gene region</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Paris</td>
<td align="left" rowspan="1" colspan="1">Institut Curie, Saint Cloud</td>
<td align="left" rowspan="1" colspan="1">686 cases</td>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em> 5′region, <em>BRCA2</em> 5′region</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Milan</td>
<td align="left" rowspan="1" colspan="1">IFOM, Fondazione Instituto FIRC di Oncologia Molecolare</td>
<td align="left" rowspan="1" colspan="1">
<ul id="humu23652-list-0001" class="list" style="list-style-type:none">
<li><p>772 cases</p></li>
<li><p>661 controls</p></li>
</ul>
</td>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em> 5′region</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Pisa</td>
<td align="left" rowspan="1" colspan="1">Department of Translational Research and New Technologies in Medicine, University of Pisa</td>
<td align="left" rowspan="1" colspan="1">80 cases</td>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em> 5′region, <em>BRCA2</em> 5′region</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Santiago de Compostela</td>
<td align="left" rowspan="1" colspan="1">Fundación Pública Galega de Medicina Xenómica‐SERGAS, Grupo de Medicina Xenómica‐USC, CIBERER, IDIS</td>
<td align="left" rowspan="1" colspan="1">
<ul id="humu23652-list-0002" class="list" style="list-style-type:none">
<li><p>270 cases</p></li>
<li><p>130 controls</p></li>
</ul>
</td>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em> 5′region, <em>BRCA2</em> 5′region</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Copenhagen</td>
<td align="left" rowspan="1" colspan="1">Center for Genomic Medicine</td>
<td align="left" rowspan="1" colspan="1">1157 cases</td>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em> 5′region, <em>BRCA2</em> 5′region</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ghent</td>
<td align="left" rowspan="1" colspan="1">Center for Medical Genetics, Ghent University Hospital</td>
<td align="left" rowspan="1" colspan="1">357 cases</td>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em> 5′region, <em>BRCA2</em> 5′region</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Barcelona</td>
<td align="left" rowspan="1" colspan="1">Vall d'Hebron Institute of Oncology</td>
<td align="left" rowspan="1" colspan="1">192 cases</td>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em> 5′region, <em>BRCA2</em> 5′region</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Prague</td>
<td align="left" rowspan="1" colspan="1">CZECANCA – CZEch CAncer panel for Clinical Aplication, Institute of Biochemistry and Experimental Oncology</td>
<td align="left" rowspan="1" colspan="1">
<ul id="humu23652-list-0003" class="list" style="list-style-type:none">
<li><p>2961 cases</p></li>
<li><p>312 controls</p></li>
</ul>
</td>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em> 5′region, <em>BRCA2</em> 5′region</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Maastricht</td>
<td align="left" rowspan="1" colspan="1">Department of Clinical Genetics, Maastricht University Medical Centre</td>
<td align="left" rowspan="1" colspan="1">900 cases</td>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em> 5′region</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/humu23652-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="humu23652-sec-0050"><h3 class="pmc_sec_title">2.3. Identification of variants</h3>
<p>Regions containing the <em>BRCA1</em> and <em>BRCA2</em> promoter and 5′ UTR were sequenced using a range of standard DNA sequencing technologies, and bioinformatic filtering pipelines. Variants mapping to the 2,400 bp region (hg19; chr17:41,278,514 – 41,276,114) of <em>BRCA1</em> and the 2,000 bp region (hg19; chr13: 32,888,597‐32,890,597) of <em>BRCA2</em> were considered for further analysis. The identified variants in <em>BRCA1</em> and <em>BRCA2</em> 5′ noncoding regions are numbered whereby the first translated nucleotide of the translation initiation codon is +1 (<a href="https://varnomen.hgvs.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://varnomen.hgvs.org/</a>) using the Mutalyzer website (<a href="https://mutalyzer.nl/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://mutalyzer.nl/</a>). <em>BRCA1</em> is described using <a href="https://www.ncbi.nlm.nih.gov/nuccore/NC_000017.10" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NC_000017.10</a> (hg19 genomic sequence) and <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.3</a> (transcript). <em>BRCA2</em> is described using <a href="https://www.ncbi.nlm.nih.gov/nuccore/NC_000013.10" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NC_000013.10</a> (hg19 genomic sequence) and <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.3</a> (transcript).</p></section><section id="humu23652-sec-0060"><h3 class="pmc_sec_title">2.4. Bioinformatic analysis of variants</h3>
<p>As an initial screen, each variant submitted for study was assessed for population frequency using intersection of the variants with dbSNP (version 138 or 150, as the study progressed) within the UCSC Genome browser and Variant Effect Predictor at ENSEMBL (<a href="https://www.ensembl.org/info/docs/tools/vep/index.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ensembl.org/info/docs/tools/vep/index.html</a>). Variants with a global minor allele frequency (MAF) of &lt; 0.01 were included in subsequent bioinformatic analyses. Further details of bioinformatics analyses to map active regulatory elements and prioritize variants for functional assays are contained in <a href="#humu23652-supl-0002" class="usa-link">Supporting Information Methods</a>. Variants were considered to be high priority for experimental analysis if they contained all of the following features: (1) resided in DNaseI or formaldehyde‐assisted isolation of regulatory elements (FAIRE) peaks, (2) coincided with high scores for DNaseI (Base Overlap Signal &gt; 40) or FAIRE (Base Overlap Signal &gt; 10) in a breast cell line, (3) resided in a region of breast cell specific TF binding, (4) overlapped with a TF consensus motif, and (5) were within an evolutionarily conserved element with a high Phastcons score (&gt;0.75). Medium priority variants lacked one or two of these features, whereas low priority variants had only one or none of these features.</p>
<section id="humu23652-sec-0070"><h4 class="pmc_sec_title">2.4.1. 
<em>In silico</em> TF binding analysis</h4>
<p>All rare variants were analyzed <em>in silico</em> using an IT‐based method (Caminsky et al., <a href="#humu23652-bib-0009" class="usa-link" aria-describedby="humu23652-bib-0009">2016</a>; Mucaki et al., <a href="#humu23652-bib-0034" class="usa-link" aria-describedby="humu23652-bib-0034">2016</a>) and a modified version of the Shannon pipeline utilizing TF information models built from ENCODE ChIP‐seq datasets (Lu, Mucaki, &amp; Rogan, <a href="#humu23652-bib-0029" class="usa-link" aria-describedby="humu23652-bib-0029">2017</a>) to assess potential effects of variants on TF binding. Details of analyses are contained in <a href="#humu23652-supl-0002" class="usa-link">Supporting Information Methods</a>.</p></section></section><section id="humu23652-sec-0080"><h3 class="pmc_sec_title">2.5. Experimental analysis of variants</h3>
<section id="humu23652-sec-0090"><h4 class="pmc_sec_title">2.5.1. Promoter reporter assays</h4>
<p>The 499 bp <em>BRCA1</em> (chr17:41,277,787‐41,277,289) and 750 bp <em>BRCA2</em> (chr13:32,889,230‐32,889,979) promoter regions were cloned into pCR‐Blunt vector (Thermo Fisher, Waltham, MA). Site‐directed mutagenesis was used to introduce variants using the primers listed in Supporting Information Table S1. Plasmids were purified using the QIAprep miniprep kit (Qiagen, Hilden, Germany) as per the manufacturer's instructions. Plasmid preparations were validated using restriction digest and DNA sequencing and inserts were shuttled into pGL3‐Basic luciferase reporter vector (Promega, Madison, WI). All plasmids for transfection were analyzed for DNA conformation on a 1% w/v agarose gel and only plasmids possessing a supercoiled conformation were used for transfections. Transfection details are described in Supporting Information Methods.</p>
<p>The luciferase‐based reporter assay was performed as described previously (Brewster et al., <a href="#humu23652-bib-0007" class="usa-link" aria-describedby="humu23652-bib-0007">2012</a>). Positive controls were B1‐Ets, <em>BRCA1</em>:c.‐330_‐329delinsTT, that decreases <em>BRCA1</em> promoter activity in MCF7 cells (Atlas, Stramwasser, Whiskin, &amp; Mueller, <a href="#humu23652-bib-0003" class="usa-link" aria-describedby="humu23652-bib-0003">2000</a>) and B2‐Ets (E2Fmut1: <em>BRCA2</em>:c.‐282_‐281delinsAA), that has been shown to decrease <em>BRCA2</em> promoter activity in MCF7 cells (Davis, Miron, Andersen, Iglehart, &amp; Marks, <a href="#humu23652-bib-0011" class="usa-link" aria-describedby="humu23652-bib-0011">1999</a>). Statistical analyses were performed in GraphPad Prism using one‐way analysis of variance followed by Tukey's post hoc test and values <em>P</em> &lt; 0.05 were deemed statistically significant.</p></section><section id="humu23652-sec-0100"><h4 class="pmc_sec_title">2.5.2. Electrophoretic mobility shift assays</h4>
<p>Nuclear proteins were extracted as described in Supporting Information Methods and electrophoretic mobility shift assays (EMSAs) were carried out using a Pierce LightShift Chemiluminescent EMSA Kit (Thermo Fisher, Waltham, MA) with modifications described in Supporting Information Methods. For competition and supershift studies, nuclear extracts were initially incubated with unlabeled double‐stranded (ds) competitor probes or antibodies in binding buffer before addition of the biotinylated probe and incubation at room temperature. Positive controls for <em>BRCA1</em> and <em>BRCA2</em> DNA binding were sequences surrounding the B1‐Ets and B2‐Ets mutations described above.</p></section></section><section id="humu23652-sec-0110"><h3 class="pmc_sec_title">2.6. Qualitative and quantitative classification of variants</h3>
<p>Variants were classified according to the ENIGMA classification criteria for variation in <em>BRCA1</em> and <em>BRCA2</em> (<a href="https://enigmaconsortium.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://enigmaconsortium.org/</a>) to determine whether any of the prioritized variants were associated with a high risk of disease. See Supporting Information Methods for further details.</p></section></section><section id="humu23652-sec-0120"><h2 class="pmc_sec_title">3. RESULTS</h2>
<section id="humu23652-sec-0130"><h3 class="pmc_sec_title">3.1. Identification and prioritization of sequence variants in <em>BRCA1</em> and <em>BRCA2</em> 5´ noncoding regions</h3>
<p>The 5′ noncoding regions of <em>BRCA1</em> and <em>BRCA2</em> in early onset or familial BC patients with no known <em>BRCA1</em> or <em>BRCA2</em> germline pathogenic variant were sequenced at nine different sites as part of an approved ENIGMA (<a href="https://enigmaconsortium.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://enigmaconsortium.org/</a>) project. For the <em>BRCA1</em> 5′ region, 6,475 patients were sequenced at eight different sites along with 1,103 controls. For the <em>BRCA2</em> 5′ region, 6,603 patients were sequenced at eight different sites as well as 442 controls.</p>
<p>After excluding variants with global MAF &gt; 0.01 at time of variant identification, a total of 141 unique single nucleotide variants and short insertions/deletions were identified, 81 in <em>BRCA1</em> and 60 in <em>BRCA2</em> (<a href="#humu23652-supl-0001" class="usa-link">Supporting Information Tables S2 and S3</a>). Theses variants have been submitted to the LOVD databases, <a href="http://www.lovd.nl/BRCA1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.lovd.nl/BRCA1</a> and <a href="http://www.lovd.nl/BRCA2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.lovd.nl/BRCA2</a>. To evaluate the potential of these rare variants to impact gene regulation, we initially undertook a comprehensive bioinformatic analysis. Promoter regions of <em>BRCA1</em> and <em>BRCA2</em> were defined by bioinformatic predictors including chromatin marks (Figure <a href="#humu23652-fig-0002" class="usa-link">2</a>). These regions show the characteristic histone H3 epigenetic marks, including H3K4me3, H3K27ac, and H3K9ac, as well as occupancy by multiple TFs. Of the variants identified in cases only, 22 <em>BRCA1</em> and 23 <em>BRCA2</em> variants resided within the minimal promoter regions.</p>
<figure class="fig xbox font-sm" id="humu23652-fig-0002" lang="en"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c15/6282814/3e1883f79a8f/HUMU-39-2025-g002.jpg" loading="lazy" id="nlm-graphic-5" height="710" width="762" alt="Figure 2"></p>
<div class="p text-right font-secondary"><a href="figure/humu23652-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Variants identified in the 5′ regions of <em>BRCA1</em> and <em>BRCA2</em> map to predicted regulatory elements. Snapshots of the UCSC genome browser showing regions of <em>BRCA1</em> (a) and <em>BRCA2</em> (b) analyzed by targeted sequencing with available ENCODE regulatory marks derived from MCF7 cells. Chromatin segregation states from regulatory region annotation are shown (MCF7 states). The <em>BRCA1</em> and <em>BRCA2</em> genomic regions used for functional analyses are highlighted in grey. Prioritized variants within these regions are indicated</p></figcaption></figure><p>To predict the potential impact of variants on promoter activity, we prioritized variants using breast cell specific data for chromatin accessibility and TF occupancy along with evolutionary conservation. Due to the limited breast cell specific TF ChIP‐seq data, we also included ENCODE TF ChIP‐seq and TF consensus motif data from all cell lines. A total of nine <em>BRCA1</em> and 12 <em>BRCA2</em> variants were selected for further functional analysis (Figure <a href="#humu23652-fig-0002" class="usa-link">2</a>; Tables <a href="#humu23652-tbl-0002" class="usa-link">2</a> and <a href="#humu23652-tbl-0003" class="usa-link">3</a>).</p>
<section class="tw xbox font-sm" id="humu23652-tbl-0002" lang="en"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>
<em>BRCA1</em> prioritized variants</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<thead><tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="1" colspan="1">Gene</th>
<th align="left" rowspan="1" colspan="1">hg19 position (chr17)</th>
<th align="left" rowspan="1" colspan="1">Variant name<a href="#humu23652-tbl2-note-0002" class="usa-link"><sup>a</sup></a>
</th>
<th align="left" rowspan="1" colspan="1">rsID</th>
<th align="left" rowspan="1" colspan="1">Global MAF in dbSNP</th>
<th align="left" rowspan="1" colspan="1">TF motif (ENCODE)<a href="#humu23652-tbl2-note-0003" class="usa-link"><sup>b</sup></a>
</th>
<th align="left" rowspan="1" colspan="1">Bioinformatic priority</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277676A&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐408T&gt;A</td>
<td align="left" rowspan="1" colspan="1">Novel</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">CEBPB</td>
<td align="left" rowspan="1" colspan="1">High/medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277648C&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐380G&gt;A</td>
<td align="left" rowspan="1" colspan="1">Novel</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">RXRA</td>
<td align="left" rowspan="1" colspan="1">High/medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277646G&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐378C&gt;A</td>
<td align="left" rowspan="1" colspan="1">rs186775935</td>
<td align="left" rowspan="1" colspan="1">0.00040</td>
<td align="left" rowspan="1" colspan="1">RXRA</td>
<td align="left" rowspan="1" colspan="1">High/medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277583del</td>
<td align="left" rowspan="1" colspan="1">c.‐315del</td>
<td align="left" rowspan="1" colspan="1">rs901029407</td>
<td align="left" rowspan="1" colspan="1">0.00003</td>
<td align="left" rowspan="1" colspan="1">ATF1,2,3, CREB1<a href="#humu23652-tbl2-note-0004" class="usa-link"><sup>c</sup></a>
</td>
<td align="left" rowspan="1" colspan="1">Medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277555G&gt;A</td>
<td align="left" rowspan="1" colspan="1">c.‐287C&gt;T</td>
<td align="left" rowspan="1" colspan="1">Novel</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">NFYA, NFYB</td>
<td align="left" rowspan="1" colspan="1">High/medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277541C&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐273G&gt;A</td>
<td align="left" rowspan="1" colspan="1">rs112960339</td>
<td align="left" rowspan="1" colspan="1">0.00499</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">Medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277532A&gt;C</td>
<td align="left" rowspan="1" colspan="1">c.‐264T&gt;G</td>
<td align="left" rowspan="1" colspan="1">rs904148166</td>
<td align="left" rowspan="1" colspan="1">0.00003</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">Medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277488G&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐220C&gt;A</td>
<td align="left" rowspan="1" colspan="1">Novel</td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">Medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277460A&gt;G</td>
<td align="left" rowspan="1" colspan="1">c.‐192T&gt;C</td>
<td align="left" rowspan="1" colspan="1">rs113323025</td>
<td align="left" rowspan="1" colspan="1">0.00519</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">Medium</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/humu23652-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="humu23652-tbl2-note-0001"><p>TF, transcription factors.</p></div>
<div class="fn" id="humu23652-tbl2-note-0002">
<sup>a</sup><p class="display-inline">Based on <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.3</a>.</p>
</div>
<div class="fn" id="humu23652-tbl2-note-0003">
<sup>b</sup><p class="display-inline">Overlap with TF motif in ENCODE TF‐ChIP datasets from all cells.</p>
</div>
<div class="fn" id="humu23652-tbl2-note-0004">
<sup>c</sup><p class="display-inline">Variant overlaps this motif, but the deletion does not alter the motif sequence.</p>
</div>
</div></section><section class="tw xbox font-sm" id="humu23652-tbl-0003" lang="en"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>
<em>BRCA2</em> prioritized variants</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<thead><tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="1" colspan="1">Gene</th>
<th align="left" rowspan="1" colspan="1">hg19 Position (Chr13)</th>
<th align="left" rowspan="1" colspan="1">Variant name<a href="#humu23652-tbl3-note-0001" class="usa-link"><sup>a</sup></a>
</th>
<th align="left" rowspan="1" colspan="1">rsID</th>
<th align="left" rowspan="1" colspan="1">Global MAF in dbSNP</th>
<th align="left" rowspan="1" colspan="1">TF motif (ENCODE)<a href="#humu23652-tbl3-note-0002" class="usa-link"><sup>b</sup></a>
</th>
<th align="left" rowspan="1" colspan="1">Bioinformatic priority</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889437G&gt;A</td>
<td align="left" rowspan="1" colspan="1">c.‐407G&gt;A</td>
<td align="left" rowspan="1" colspan="1">rs36221751</td>
<td align="left" rowspan="1" colspan="1">0.0018</td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1">Medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889449C&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐395C&gt;T</td>
<td align="left" rowspan="1" colspan="1">Novel</td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1">Medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889548C&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐296C&gt;T</td>
<td align="left" rowspan="1" colspan="1">rs563971900</td>
<td align="left" rowspan="1" colspan="1">0.0004</td>
<td align="left" rowspan="1" colspan="1">PAX5</td>
<td align="left" rowspan="1" colspan="1">High/medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889564delG</td>
<td align="left" rowspan="1" colspan="1">c.‐280del</td>
<td align="left" rowspan="1" colspan="1">Novel</td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1">ELF1, GABPA, ELK1,4</td>
<td align="left" rowspan="1" colspan="1">High</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889576C&gt;G</td>
<td align="left" rowspan="1" colspan="1">c.‐268C&gt;G</td>
<td align="left" rowspan="1" colspan="1">Novel</td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1">High/medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889626G&gt;A</td>
<td align="left" rowspan="1" colspan="1">c.‐218G&gt;A</td>
<td align="left" rowspan="1" colspan="1">Novel</td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1">Medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889644C&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐200C&gt;T</td>
<td align="left" rowspan="1" colspan="1">Novel</td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1">MAZ</td>
<td align="left" rowspan="1" colspan="1">Medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889647A&gt;C</td>
<td align="left" rowspan="1" colspan="1">c.‐197A&gt;C</td>
<td align="left" rowspan="1" colspan="1">rs370721506</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">MAZ</td>
<td align="left" rowspan="1" colspan="1">Medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889669C&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐175C&gt;T</td>
<td align="left" rowspan="1" colspan="1">rs55880202</td>
<td align="left" rowspan="1" colspan="1">0.0058</td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1">Medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889711T&gt;G</td>
<td align="left" rowspan="1" colspan="1">c.‐133T&gt;G</td>
<td align="left" rowspan="1" colspan="1">Novel</td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1">Medium</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889757T&gt;G</td>
<td align="left" rowspan="1" colspan="1">c.‐87T&gt;G</td>
<td align="left" rowspan="1" colspan="1">Novel</td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1">Medium/low</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889762G&gt;C</td>
<td align="left" rowspan="1" colspan="1">c.‐82G&gt;C</td>
<td align="left" rowspan="1" colspan="1">Novel</td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1">Medium/low</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/humu23652-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="humu23652-tbl3-note-0003"><p>NA, no data available, TF, transcription factors.</p></div>
<div class="fn" id="humu23652-tbl3-note-0001">
<sup>a</sup><p class="display-inline">Based on <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.3</a>.</p>
</div>
<div class="fn" id="humu23652-tbl3-note-0002">
<sup>b</sup><p class="display-inline">Overlap with TF motif in ENCODE TF‐ChIP datasets from all cells.</p>
</div>
</div></section></section><section id="humu23652-sec-0140"><h3 class="pmc_sec_title">3.2. 
<em>BRCA1</em> and <em>BRCA2</em> promoter activity is altered by 5′ noncoding sequence variants</h3>
<p>To examine the potential effect of the 21 prioritized <em>BRCA1</em> and <em>BRCA2</em> 5′ noncoding variants on regulatory activity, promoter activity was measured using luciferase assays in MCF7 and MDA‐MB‐468 BC cell lines. Two of the nine prioritized <em>BRCA1</em> variants decreased <em>BRCA1</em> promoter activity relative to the wild‐type (WT) construct (Figure <a href="#humu23652-fig-0003" class="usa-link">3</a>a and 3b). <em>BRCA1</em>:c.‐315del significantly decreased the <em>BRCA1</em> promoter luciferase activity in both cell lines, whereas <em>BRCA1</em>:c.‐192C decreased luciferase activity in the MCF7 cell line. Furthermore, one variant, <em>BRCA1</em>:c.‐287T, displayed increased activity relative to the WT construct in the MCF7 cell line. For <em>BRCA2</em>, one of the 12 variants, <em>BRCA2</em>:c.‐296T, decreased <em>BRCA2</em> promoter activity relative to the WT construct in the MCF7 cell line (Figure <a href="#humu23652-fig-0003" class="usa-link">3</a>c and 3d).</p>
<figure class="fig xbox font-sm" id="humu23652-fig-0003" lang="en"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c15/6282814/3c940b3f9edb/HUMU-39-2025-g003.jpg" loading="lazy" id="nlm-graphic-7" height="680" width="760" alt="Figure 3"></p>
<div class="p text-right font-secondary"><a href="figure/humu23652-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Variants mapping to the 5′ regions of <em>BRCA1</em> and <em>BRCA2</em> alter promoter activity in MCF7 and MDA‐MB‐468 breast cancer cells. MCF7 (a and c) and MDA‐MB‐468 cells (b and d) were transfected with pGL3 vectors where luciferase expression is controlled by a portion of the <em>BRCA1</em> (B1) (a and b) or <em>BRCA2</em> (B2) (c and d) promoter. Cells were transfected with plasmids containing the wild‐type (WT) promoter sequence (grey bars), positive control (B1‐Ets or B2‐Ets; striped bars) or the indicated variants (black bars). Luciferase expression was normalized to a cotransfected pRL‐TK plasmid. Data represent the average of three independent biological replicates ± standard deviation (<em>SD</em>). The horizontal dotted line represents WT promoter activity set at 1.0‐fold. The vertical dotted lines demarcate individual experiments that include WT, positive control, and variant containing plasmids. (* <em>P</em> ˂ 0.05; ** <em>P</em> ˂ 0.01, *** <em>P</em> ˂ 0.005, **** <em>P</em> ˂ 0.0001)</p></figcaption></figure></section><section id="humu23652-sec-0150"><h3 class="pmc_sec_title">3.3. 
<em>In silico</em> analyses of <em>BRCA1</em> and <em>BRCA2</em> 5′ variants predict alterations in TF binding</h3>
<p>
<em>BRCA1</em> and <em>BRCA2</em> promoters are regulated by a complex array of DNA‐binding proteins and transcriptional coactivators and corepressors (reviewed in McCoy, Mueller, &amp; Roskelley, <a href="#humu23652-bib-0031" class="usa-link" aria-describedby="humu23652-bib-0031">2003</a>; Mueller &amp; Roskelley, <a href="#humu23652-bib-0035" class="usa-link" aria-describedby="humu23652-bib-0035">2003</a>; Wiedemeyer et al., <a href="#humu23652-bib-0059" class="usa-link" aria-describedby="humu23652-bib-0059">2014</a>). In silico analysis was carried out to examine whether the <em>BRCA1</em> and <em>BRCA2</em> promoter variants shown to alter luciferase activity (see above) are likely to affect binding of trans‐acting protein factors in breast cells.</p>
<p>Interrogation of ENCODE ChIP‐seq datasets derived from breast cell lines show that, although the number of datasets is limited, TFs bind to regions encompassing the prioritized variants (Figure <a href="#humu23652-fig-0002" class="usa-link">2</a> and <a href="#humu23652-supl-0001" class="usa-link">Supporting Information Figure S1</a>). ENCODE ChIP‐seq data from other cell lines indicate that some variants are located within consensus motifs for specific TFs associated with these regions (Tables <a href="#humu23652-tbl-0002" class="usa-link">2</a> and <a href="#humu23652-tbl-0003" class="usa-link">3</a>; <a href="#humu23652-supl-0001" class="usa-link">Supporting Information Figure S1</a>). <em>BRCA1:c</em>.‐287C&gt;T overlaps with the consensus binding motif for CCAAT Box binding factors and <em>BRCA2:c</em>.‐296C&gt;T is located within the consensus motif for PAX5.</p>
<p>IT analysis of the prioritized variants showed that the binding strengths of several TFs are predicted to be altered by the <em>BRCA1</em> and <em>BRCA2</em> variants (Table <a href="#humu23652-tbl-0004" class="usa-link">4</a> and <a href="#humu23652-supl-0001" class="usa-link">Supporting Information Table S4</a>). All of the variants that altered promoter activity were predicted to have consequences on TF binding. <em>BRCA1</em>:c.‐287C&gt;T and <em>BRCA2</em>:c.‐296C&gt;T are predicted to disrupt binding of CCAAT Box binding factors and PAX5, respectively. <em>BRCA1</em>:c.‐315del is predicted to disrupt the binding of TCF7L2 but creates a POU2F2 (also known as Oct‐2) binding site. <em>BRCA1</em>:c.‐192T&gt;C is predicted to strengthen a RFX5 site and creates an ETS1 site.</p>
<section class="tw xbox font-sm" id="humu23652-tbl-0004" lang="en"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Information theory analysis of prioritized <em>BRCA1/2</em> variants</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<thead><tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="1" colspan="1">Variant name</th>
<th align="left" rowspan="1" colspan="1">TF motif (ENCODE)</th>
<th align="left" rowspan="1" colspan="1">Consequences</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>:c.‐408T&gt;A</td>
<td align="left" rowspan="1" colspan="1">CEBPB</td>
<td align="left" rowspan="1" colspan="1">CEBPB site weakened (did not meet stringent filtering thresholds)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>:c.‐380G&gt;A</td>
<td align="left" rowspan="1" colspan="1">RXRA</td>
<td align="left" rowspan="1" colspan="1">Weak RXRA and IRF3 sites weakened, HNF4G site weakened.</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>:c.‐378C&gt;A</td>
<td align="left" rowspan="1" colspan="1">RXRA</td>
<td align="left" rowspan="1" colspan="1">RXR unchanged, HSF1 site lost and GR site created</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>:c.‐315del</td>
<td align="left" rowspan="1" colspan="1">ATF1,2,3, CREB1<a href="#humu23652-tbl4-note-0001" class="usa-link"><sup>a</sup></a>
</td>
<td align="left" rowspan="1" colspan="1">TCF7L2 site lost and POU2F2 created</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>:c.‐287C&gt;T</td>
<td align="left" rowspan="1" colspan="1">NFYA, NFYB</td>
<td align="left" rowspan="1" colspan="1">NFYA and NFYB sites lost, weak PBX3 site created</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>:c.‐273G&gt;A</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">Altered TF strength did not fulfill stringent filtering thresholds<a href="#humu23652-tbl4-note-0002" class="usa-link"><sup>b</sup></a>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>:c.‐264T&gt;G</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">BHLHE32 and MYC sites created.</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>:c.‐220C&gt;A</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">Altered TF strength did not fulfill stringent filtering thresholds<a href="#humu23652-tbl4-note-0002" class="usa-link"><sup>b</sup></a>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>:c.‐192T&gt;C</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">ETS1 site created, weak RFX5 site strengthened.</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>:c.‐407G&gt;A</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">Weak MEF2A site strengthened, GATA2 site lost.</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>:c.‐395C&gt;T</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">TEAD4 site lost.</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>:c.‐296C&gt;T</td>
<td align="left" rowspan="1" colspan="1">PAX5</td>
<td align="left" rowspan="1" colspan="1">PAX5 site weakened.</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>:c.‐280del</td>
<td align="left" rowspan="1" colspan="1">ELF1, GABPA, ELK1,4</td>
<td align="left" rowspan="1" colspan="1">GABPA site unchanged, MXI1 andTCF3 sites lost.</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>:c.‐268C&gt;G</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">Altered TF strength did not meet filtering thresholds<a href="#humu23652-tbl4-note-0002" class="usa-link"><sup>b</sup></a>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>:c.‐218G&gt;A</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">Altered TF strength did not meet filtering thresholds<a href="#humu23652-tbl4-note-0002" class="usa-link"><sup>b</sup></a>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>:c.‐200C&gt;T</td>
<td align="left" rowspan="1" colspan="1">MAZ<a href="#humu23652-tbl4-note-0003" class="usa-link"><sup>c</sup></a>
</td>
<td align="left" rowspan="1" colspan="1">KLF1 site abolished.</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>:c.‐197A&gt;C</td>
<td align="left" rowspan="1" colspan="1">MAZ<a href="#humu23652-tbl4-note-0003" class="usa-link"><sup>c</sup></a>
</td>
<td align="left" rowspan="1" colspan="1">SP4 weakened, GR site weakened, TCF3 site created</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>:c.‐175C&gt;T</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">Altered TF strength did not fulfill stringent filtering thresholds<a href="#humu23652-tbl4-note-0002" class="usa-link"><sup>b</sup></a>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>:c.‐133T&gt;G</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">Altered TF strength did not fulfill stringent filtering thresholds<a href="#humu23652-tbl4-note-0002" class="usa-link"><sup>b</sup></a>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>:c.‐87T&gt;G</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">Altered TF strength did not fulfill stringent filtering thresholds<a href="#humu23652-tbl4-note-0002" class="usa-link"><sup>b</sup></a>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>:c.‐82G&gt;C</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">Altered TF strength did not fulfill stringent filtering thresholds<a href="#humu23652-tbl4-note-0002" class="usa-link"><sup>b</sup></a>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/humu23652-tbl-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="humu23652-tbl4-note-0001">
<sup>a</sup><p class="display-inline">Variant overlaps this motif, but the deletion does not alter the motif sequence.</p>
</div>
<div class="fn" id="humu23652-tbl4-note-0002">
<sup>b</sup><p class="display-inline">Change in information did not fulfill stringent filtering criteria, where [A] site <em>R</em>
<sub>i</sub> &lt; <em>R</em>
<sub>sequence</sub>–1 standard deviation of TF model, or [B] where Δ<em>R</em>
<sub>i</sub> &lt; 4 bits.</p>
</div>
<div class="fn" id="humu23652-tbl4-note-0003">
<sup>c</sup><p class="display-inline">No MAZ binding model available.</p>
</div>
</div></section></section><section id="humu23652-sec-0160"><h3 class="pmc_sec_title">3.4. 5′ variants in <em>BRCA1</em> and <em>BRCA2</em> alter protein–DNA interactions in EMSA analyses</h3>
<p>To examine potential alterations in the binding of nuclear proteins from breast cells by the <em>BRCA1</em> and <em>BRCA2</em> promoter variants that altered luciferase activity, we carried out EMSA analysis. For <em>BRCA1</em>, two of three analyzed variants, c.‐315del and c.‐287C&gt;T, displayed allele‐specific protein binding (Figure <a href="#humu23652-fig-0004" class="usa-link">4</a>). For probes containing the region surrounding the <em>BRCA1</em>:c.‐315del variant, changing the WT sequence to the variant sequence resulted in the enhanced binding of a slower migrating band (Figure <a href="#humu23652-fig-0004" class="usa-link">4</a>a and 4b). For probes containing the region surrounding the <em>BRCA1</em>:c.‐287C˃T variant, introduction of the variant sequence resulted in almost complete loss of protein binding to the probe (Figure <a href="#humu23652-fig-0004" class="usa-link">4</a>a).</p>
<figure class="fig xbox font-sm" id="humu23652-fig-0004" lang="en"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c15/6282814/868bc3f77d99/HUMU-39-2025-g004.jpg" loading="lazy" id="nlm-graphic-9" height="530" width="796" alt="Figure 4"></p>
<div class="p text-right font-secondary"><a href="figure/humu23652-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Variants in the 5′ regions of <em>BRCA1</em> alter DNA:protein complex formation. Electrophoretic mobility shift assay (EMSA) reactions were performed with 3′ biotinylated double‐stranded DNA probes from the <em>BRCA1</em> 5′ region and nuclear extracts (NE) from (a) MCF7 or (b) MDA‐MB‐468 cells. DNA probes contained either wild‐type (WT) or variant (Var) sequences. Free unbound probe (FP) and probe bound by nuclear proteins (BP) are indicated</p></figcaption></figure><p>To determine if the DNA‐protein interactions were specific, competition experiments were performed. In the case of <em>BRCA1</em>:c.‐315del, all bands were competed by both the WT and the variant containing probes in two cell lines (Figure <a href="#humu23652-fig-0005" class="usa-link">5</a>a and 5b). For <em>BRCA1</em>:c.‐287C&gt;T, only the WT probe was able to compete for binding (Figure <a href="#humu23652-fig-0005" class="usa-link">5</a>c). The nonspecific probe from an unrelated region of the <em>BRCA1</em> promoter did not compete any bands showing that the bands seen in the EMSA were specific.</p>
<figure class="fig xbox font-sm" id="humu23652-fig-0005" lang="en"><h4 class="obj_head">Figure 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c15/6282814/7bcf7dc41464/HUMU-39-2025-g005.jpg" loading="lazy" id="nlm-graphic-11" height="617" width="762" alt="Figure 5"></p>
<div class="p text-right font-secondary"><a href="figure/humu23652-fig-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Variant sequences in the <em>BRCA1</em> 5′ region alter specific DNA:protein complex formation. Competition electrophoretic mobility shift assay (EMSAs) were performed using 3′ biotinylated double‐stranded DNA probes containing sequences from the <em>BRCA1</em> 5′ region surrounding the B1:c.‐315del (a and b) and B1:c.‐287C&gt;T (c) variants. DNA probes containing the wild‐type (WT) or variant (Var) sequence were incubated with nuclear extracts from MCF7 cells (MCF7 NE) or MDA‐MB 468 cells (468 NE) in the presence (+) or absence (–) of unlabeled WT, Var, or nonspecific (NS) competitor (Comp) DNA. Free unbound probe (FP) and specific DNA:protein complexes (arrowheads) are indicated. Supershift experiments (d) were performed with the <em>BRCA1</em>:c.‐287C (WT) probe and antibodies to NFYA, Oct‐2 (POU2F2) and PAX5. The supershifted NFYA complex is indicated by asterisk (*)</p></figcaption></figure><p>Analysis of the regions of the <em>BRCA2</em> promoter using EMSA revealed that region containing the <em>BRCA2</em>:c.‐296C&gt;T variant bound nuclear proteins from MCF7 nuclear extracts and that this interaction was dramatically reduced by introduction of the variant sequence (Figure <a href="#humu23652-fig-0006" class="usa-link">6</a>a). Competition experiments showed that these interactions were specific and not competed by a nonspecific probe from an unrelated region of the <em>BRCA1</em> promoter (Figure <a href="#humu23652-fig-0006" class="usa-link">6</a>a).</p>
<figure class="fig xbox font-sm" id="humu23652-fig-0006" lang="en"><h4 class="obj_head">Figure 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c15/6282814/0c0f8d5aaf83/HUMU-39-2025-g006.jpg" loading="lazy" id="nlm-graphic-13" height="212" width="560" alt="Figure 6"></p>
<div class="p text-right font-secondary"><a href="figure/humu23652-fig-0006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Variants in the 5′ region of <em>BRCA2</em> alter specific DNA:protein complex formation. Competition electrophoretic mobility shift assay (EMSAs; a) were performed using 3′ biotinylated double‐stranded (ds) DNA probes containing sequences from the <em>BRCA2</em> 5′ region surrounding the BRCA2:c.‐296C&gt;T variant. DNA probes containing the wild‐type (WT) or variant (Var) sequence were incubated with nuclear extracts from MCF7 cells (MCF7 NE) in the presence (+) or absence (–) of unlabeled WT, Var, or nonspecific (NS) competitor (Comp) DNA. Cross‐competition EMSAs (b) contained <em>BRCA2</em> WT sequences and increasing concentrations of ds competitor DNA containing unlabeled WT, Var, or PAX5 binding sites from the <em>hCD19</em> gene and D‐amino acid oxidase gene (<em>hDAO</em>). Free unbound probe (FP) and specific DNA:protein complexes (arrowheads) are indicated</p></figcaption></figure><p>To determine the effect of these variants on the binding of specific TFs, competition and supershift analyses were performed. <em>BRCA1</em>:c.‐287C&gt;T overlaps with the consensus binding motif for CCAAT Box binding factors, NFYA and NFYB (Table <a href="#humu23652-tbl-0002" class="usa-link">2</a> and <a href="#humu23652-supl-0001" class="usa-link">Supporting Information Figure S1a</a>), and IT analysis predicts that the variant disrupts binding of these TFs (Table <a href="#humu23652-tbl-0004" class="usa-link">4</a>). Consistent with these predictions, supershift experiments show that <em>BRCA1</em>:c.‐287C&gt;T disrupts binding of NFYA to this region (Figure. <a href="#humu23652-fig-0005" class="usa-link">5</a>d). In addition, we analyzed <em>BRCA2</em>:c.‐296C&gt;T, which maps within the consensus binding motif for PAX5 (Table <a href="#humu23652-tbl-0002" class="usa-link">2</a> and <a href="#humu23652-supl-0001" class="usa-link">Supporting Information Figure S1b</a>), and is predicted by IT analysis to disrupt binding of PAX5 (Table <a href="#humu23652-tbl-0004" class="usa-link">4</a>), by cross‐competition experiments using known PAX5 binding sites from <em>hCD19</em> (Kozmik, Wang, Dorfler, Adams, &amp; Busslinger, <a href="#humu23652-bib-0026" class="usa-link" aria-describedby="humu23652-bib-0026">1992</a>) and <em>hDAO</em> (Tran et al., <a href="#humu23652-bib-0056" class="usa-link" aria-describedby="humu23652-bib-0056">2015</a>) genes. These experiments show that known PAX5 binding sites compete efficiently for binding of nuclear proteins to the <em>BRCA2</em> promoter region, indicating that PAX5 binding is reduced as a consequence of the nucleotide sequence change (Figure. <a href="#humu23652-fig-0006" class="usa-link">6</a>b). In contrast, supershift experiments for POU2F2 (Oct‐2) showed no evidence for <em>BRCA1</em>:c.‐315del causing a change in binding of POU2F2 in the cell line used (data not shown).</p></section><section id="humu23652-sec-0170"><h3 class="pmc_sec_title">3.5. Clinical classification of <em>BRCA1</em> and <em>BRCA2</em> 5′ noncoding sequence variants</h3>
<p>Variants were classified according to the ENIGMA guidelines, which are calibrated for classification of variants as high risk, using available population frequency and/or clinical data (<a href="#humu23652-supl-0001" class="usa-link">Supporting Information Tables S5 and S6</a>). In this context, the term pathogenicity refers to a variant that confers a high risk of disease. Importantly, these classification guidelines do not identify those variants that confer a moderate or low risk of disease.</p>
<p>Of those variants identified in cases only, 26/70 (37%) of BRCA1 variants had been reported in dbSNP at study initiation (maximum global frequency = 0.006; <a href="#humu23652-supl-0001" class="usa-link">Supporting Information Table S2</a>), and 22/54 (41%) of <em>BRCA2</em> variants observed in cases only were identified in dbSNP (maximum global frequency = 0.006; <a href="#humu23652-supl-0001" class="usa-link">Supporting Information Table S3</a>). Review of variant frequency in public reference groups identified 21 variants that were classifiable, as Not Pathogenic, based on frequency in control groups (<a href="#humu23652-supl-0001" class="usa-link">Supporting Information Table S5</a>): six <em>BRCA1</em> and five <em>BRCA2</em> variants were observed at &gt;1% frequency in population subgroups (stand‐alone evidence against pathogenicity, when detected in a nonfounder outbred population group); six <em>BRCA1</em> and four <em>BRCA2</em> variants occurred at frequency 0.001–0.01 (range 0.0014–0.0076) in at least five individuals in the reference set, which combined with a low assumed prior is considered sufficient as evidence against pathogenicity (<a href="#humu23652-supl-0001" class="usa-link">Supporting Information Table S5</a>). Frequency data from controls screened for this study also supported the frequency‐based classifications for eight of these 21 variants (<a href="#humu23652-supl-0001" class="usa-link">Supporting Information Table S5</a>).</p>
<p>Segregation analysis for seven informative families aided classification for six variants, whereas histopathology likelihood ratios (LRs) derived for 24 tumors altered classification for 10 variants (<a href="#humu23652-supl-0001" class="usa-link">Supporting Information Table S6</a>). Combining findings from qualitative and quantitative methods, most variants (113/141; 80%) remained Class 3 Uncertain, largely due to a lack of data.</p>
<p>A total of 27/141 (19%) variants were classified as Not Pathogenic or Likely Not Pathogenic. Of the 21 variants prioritized for functional analysis, eight variants (38%) were classified as Not Pathogenic or Likely Not Pathogenic based on frequency information and/or multifactorial analysis (Table <a href="#humu23652-tbl-0005" class="usa-link">5</a>), including two variants (<em>BRCA1:c</em>.‐192T&gt;C and <em>BRCA2:c</em>.‐296 C &gt; T) that were shown to decrease promoter activity and in the case of <em>BRCA2:c</em>.‐296 C&gt;T also resulted in perturbed TF binding. Taken together this analysis indicates that none of the variants shown to affect function in this study are associated with a high risk of disease. This analysis is silent, however, on whether these variants may confer a moderate or low risk of disease.</p>
<section class="tw xbox font-sm" id="humu23652-tbl-0005" lang="en"><h4 class="obj_head">Table 5.</h4>
<div class="caption p"><p>Classification of prioritized variants</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<col align="left" span="1">
<thead><tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="1" colspan="1">Gene</th>
<th align="left" rowspan="1" colspan="1">Genomic location (hg19)</th>
<th align="left" rowspan="1" colspan="1">HGVS c. nomenclature</th>
<th align="left" rowspan="1" colspan="1">Luciferase result</th>
<th align="left" rowspan="1" colspan="1">Combined interpretation of frequency data &amp; multifactorial analysis</th>
<th align="left" rowspan="1" colspan="1">Highest MAF (population, database)</th>
<th align="left" rowspan="1" colspan="1">Prior probability of pathogenicity</th>
<th align="left" rowspan="1" colspan="1">Segregation Bayes score (# families)</th>
<th align="left" rowspan="1" colspan="1">Tumor histopathology likelihood ratio (# tumors)</th>
<th align="left" rowspan="1" colspan="1">Combined odds for causality</th>
<th align="left" rowspan="1" colspan="1">Posterior probability of pathogenicity<a href="#humu23652-tbl5-note-0003" class="usa-link"><sup>c</sup></a>
</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277676A&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐408T&gt;A</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Uncertain</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277648C&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐380G&gt;A</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Uncertain</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">1.67 (1)</td>
<td align="left" rowspan="1" colspan="1">1.67</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277646G&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐378C&gt;A</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Uncertain</td>
<td align="left" rowspan="1" colspan="1">0.0015 (African, 1,000 Genomes)</td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277583del</td>
<td align="left" rowspan="1" colspan="1">c.‐315del</td>
<td align="left" rowspan="1" colspan="1">Decrease</td>
<td align="left" rowspan="1" colspan="1">Uncertain</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277555G&gt;A</td>
<td align="left" rowspan="1" colspan="1">c.‐287C&gt;T</td>
<td align="left" rowspan="1" colspan="1">Increase</td>
<td align="left" rowspan="1" colspan="1">Uncertain</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.64 (1)</td>
<td align="left" rowspan="1" colspan="1">0.64</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277541C&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐273G&gt;A</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Not pathogenic<a href="#humu23652-tbl5-note-0001" class="usa-link"><sup>a</sup></a>
</td>
<td align="left" rowspan="1" colspan="1">0.0159 (African, 1,000 Genomes)</td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277532A&gt;C</td>
<td align="left" rowspan="1" colspan="1">c.‐264T&gt;G</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Uncertain</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.51 (1)</td>
<td align="left" rowspan="1" colspan="1">0.51</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277488G&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐220C&gt;A</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Uncertain</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="left" rowspan="1" colspan="1">g.41277460A&gt;G</td>
<td align="left" rowspan="1" colspan="1">c.‐192T&gt;C</td>
<td align="left" rowspan="1" colspan="1">Decrease</td>
<td align="left" rowspan="1" colspan="1">Not pathogenic<a href="#humu23652-tbl5-note-0001" class="usa-link"><sup>a</sup></a>
</td>
<td align="left" rowspan="1" colspan="1">0.0159 (African, 1,000 Genomes)</td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889437G&gt;A</td>
<td align="left" rowspan="1" colspan="1">c.‐407G&gt;A</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Not pathogenic<a href="#humu23652-tbl5-note-0002" class="usa-link"><sup>b</sup></a>
</td>
<td align="left" rowspan="1" colspan="1">0.0080 (Prague, this study)</td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.55 (6)</td>
<td align="left" rowspan="1" colspan="1">0.55</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889449C&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐395C&gt;T</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Uncertain</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889548C&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐296C&gt;T</td>
<td align="left" rowspan="1" colspan="1">Decrease</td>
<td align="left" rowspan="1" colspan="1">Not pathogenic<a href="#humu23652-tbl5-note-0002" class="usa-link"><sup>b</sup></a>
</td>
<td align="left" rowspan="1" colspan="1">0.0080 (Prague, this study)</td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1">3.07 (1)</td>
<td align="left" rowspan="1" colspan="1">1.91 (8)</td>
<td align="left" rowspan="1" colspan="1">5.87</td>
<td align="left" rowspan="1" colspan="1">0.1069</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889564delG</td>
<td align="left" rowspan="1" colspan="1">c.‐280del</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Uncertain</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.69 (1)</td>
<td align="left" rowspan="1" colspan="1">0.69</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889576C&gt;G</td>
<td align="left" rowspan="1" colspan="1">c.‐268C&gt;G</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Uncertain</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889626G&gt;A</td>
<td align="left" rowspan="1" colspan="1">c.‐218G&gt;A</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Likely not pathogenic</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1">0.52 (1)</td>
<td align="left" rowspan="1" colspan="1">0.72 (1)</td>
<td align="left" rowspan="1" colspan="1">0.38</td>
<td align="left" rowspan="1" colspan="1">0.0076</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889644C&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐200C&gt;T</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Likely not pathogenic</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.37 (1)</td>
<td align="left" rowspan="1" colspan="1">0.37</td>
<td align="left" rowspan="1" colspan="1">0.0075</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889647A&gt;C</td>
<td align="left" rowspan="1" colspan="1">c.‐197A&gt;C</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Not pathogenic<a href="#humu23652-tbl5-note-0002" class="usa-link"><sup>b</sup></a>
</td>
<td align="left" rowspan="1" colspan="1">0.0014 (African, FLOSSIES)</td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">1.08 (1)</td>
<td align="left" rowspan="1" colspan="1">1.08</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889669C&gt;T</td>
<td align="left" rowspan="1" colspan="1">c.‐175C&gt;T</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Not pathogenic<a href="#humu23652-tbl5-note-0001" class="usa-link"><sup>a</sup></a>
</td>
<td align="left" rowspan="1" colspan="1">0.0197 (African, FLOSSIES)</td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889711T&gt;G</td>
<td align="left" rowspan="1" colspan="1">c.‐133T&gt;G</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Uncertain</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889757T&gt;G</td>
<td align="left" rowspan="1" colspan="1">c.‐87T&gt;G</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Uncertain</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="left" rowspan="1" colspan="1">g.32889762G&gt;C</td>
<td align="left" rowspan="1" colspan="1">c.‐82G&gt;C</td>
<td align="left" rowspan="1" colspan="1">No effect</td>
<td align="left" rowspan="1" colspan="1">Uncertain</td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1">0.02</td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/humu23652-tbl-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="humu23652-tbl5-note-0004"><p>NA, not applicable: multifactorial classification not assigned as the combined odds of causality were insufficient (≥0.5 and ≤2) to derive a posterior probability of pathogenicity (Vallee et al., <a href="#humu23652-bib-0063" class="usa-link" aria-describedby="humu23652-bib-0063">2016</a>).</p></div>
<div class="fn" id="humu23652-tbl5-note-0001">
<sup>a</sup><p class="display-inline">Not pathogenic based on frequency &gt; 1% in an outbred sampleset.</p>
</div>
<div class="fn" id="humu23652-tbl5-note-0002">
<sup>b</sup><p class="display-inline">Variant allele assigned a low prior probability of pathogenicity of 0.02 assuming conservatively that 2/100 of such variants might be associated with a high risk of cancer and allele frequency ≥0.001 and &lt; 0.01 in outbred sample set.</p>
</div>
<div class="fn" id="humu23652-tbl5-note-0003">
<sup>c</sup><p class="display-inline">Posterior probabilities used to assign IARC 5‐tier class as described in Plon et al., <a href="#humu23652-bib-0039" class="usa-link" aria-describedby="humu23652-bib-0039">2008</a>.</p>
</div>
</div></section></section></section><section id="humu23652-sec-0180"><h2 class="pmc_sec_title">4. DISCUSSION</h2>
<p>Next generation sequencing and gene panel testing enable rapid analysis of gene regions that have previously not been included in standard screening procedures, including promoters, UTRs, introns, and extragenic regions. It is hypothesized that variants in these regions have potential to modulate gene expression (Stranger et al., <a href="#humu23652-bib-0051" class="usa-link" aria-describedby="humu23652-bib-0051">2005</a>; Stranger et al., <a href="#humu23652-bib-0052" class="usa-link" aria-describedby="humu23652-bib-0052">2007</a>) and impact on relative disease risk, possibly in collaboration with multiple other low‐, moderate‐, and high‐risk variants (Manolio et al., <a href="#humu23652-bib-0030" class="usa-link" aria-describedby="humu23652-bib-0030">2009</a>). This extends and validates our previous study (Santana dos Santos et al., <a href="#humu23652-bib-0044" class="usa-link" aria-describedby="humu23652-bib-0044">2017</a>) by using a larger number patients analyzed over nine geographical locations, identifying additional BC‐associated variants, and showing that a subset of these variants modulate binding of specific TFs. Further, we have compared results from our bioinformatics and functional analysis to variant classifications based on ENIGMA <em>BRCA1/2</em> guidelines for high‐risk variation in these genes.</p>
<p>Through targeted sequencing of over 6,000 early onset/familial BC patients, we identified 141 single nucleotide variants and small indels mapping to the 5′ noncoding regions of BRCA1 and BRCA2. Of these, four (<em>BRCA1</em>:c.‐315del, <em>BRCA1</em>:c.‐287C&gt;T, <em>BRCA1</em>:c.‐192T&gt;C, and <em>BRCA2</em>:c.‐296C&gt;T) caused a significant change in promoter activity. The observed alterations in <em>BRCA1</em> and <em>BRCA2</em> promoter activity are of a similar magnitude to that seen with other germline variants associated with BC risk (Michailidou et al., <a href="#humu23652-bib-0032" class="usa-link" aria-describedby="humu23652-bib-0032">2017</a>), including a variant in the <em>TERT</em> promoter, which creates a new binding site for Ets factors and results in a 1.2–1.5‐fold increase in luciferase activity in a promoter reporter assay (Horn et al., <a href="#humu23652-bib-0024" class="usa-link" aria-describedby="humu23652-bib-0024">2013</a>), and variants in the promoters of <em>KLHDC7A</em> and <em>PIDD1</em> (Michailidou et al., <a href="#humu23652-bib-0032" class="usa-link" aria-describedby="humu23652-bib-0032">2017</a>). Although this supports the hypothesis that moderate change in promoter activity can be associated with disease risk, further work is needed to confirm this.</p>
<p>One of the four variants significantly altered luciferase activity in both tested cell lines, whereas the remaining three variants only affected luciferase activity in MCF7 cells. This may reflect the differential availability of crucial TFs in MDA‐MB‐468 cells (Kao et al., <a href="#humu23652-bib-0025" class="usa-link" aria-describedby="humu23652-bib-0025">2009</a>) and highlights the importance of undertaking that assays for functional activity of variants in more than one cell line. Three variants, <em>BRCA1</em>:c.‐380G&gt;A, <em>BRCA2</em>:c.‐296C&gt;T, and <em>BRCA2</em>:c.‐218G&gt;A, were also analyzed in our earlier paper (Santana dos Santos et al., <a href="#humu23652-bib-0044" class="usa-link" aria-describedby="humu23652-bib-0044">2017</a>). Although the cell lines used in the two studies were different (MDA‐MB‐231 in Santana dos Santos et al., <a href="#humu23652-bib-0044" class="usa-link" aria-describedby="humu23652-bib-0044">2017</a> and MCF7 and MDA‐MB‐468 here), the trends are the same in five out of six analyses. The difference for <em>BRCA2</em>:c.‐296C&gt;T, which causes a significant decrease in MDA‐MB‐231 and MCF7 cells, but not MDA‐MB‐468 cells, may again be indicative of differential gene expression in BC cell lines (Kao et al., <a href="#humu23652-bib-0025" class="usa-link" aria-describedby="humu23652-bib-0025">2009</a>). Overall, however, the consistency of results performed in two separate laboratories underscores the robustness of the assay system.</p>
<p>Some variants were associated with a decrease in promoter activity, whereas others were associated with an increase. As TFs can function as activators or repressors, a variant‐associated change in TF binding can result in either a decrease or an increase in promoter (or other regulatory element) activity. Differences in the quanta and direction of promoter activity have been reported previously (e.g., Fraile‐Bethencourt et al., <a href="#humu23652-bib-0017" class="usa-link" aria-describedby="humu23652-bib-0017">2018</a>; Santana dos Santos et al., <a href="#humu23652-bib-0044" class="usa-link" aria-describedby="humu23652-bib-0044">2017</a>) and have also been shown to differ between cell lines potentially reflecting the availability of TFs or cofactors (e.g., Zn).</p>
<p>Three of the variants, <em>BRCA1</em>:c.‐315del, <em>BRCA1</em>: c.‐287C&gt;T, and <em>BRCA2</em>:c.‐296C&gt;T, altered protein binding. ENCODE ChIP‐seq data from BC cell lines indicate candidate proteins that are bound to the genomic regions containing these variants (Figure <a href="#humu23652-fig-0002" class="usa-link">2</a> and <a href="#humu23652-supl-0001" class="usa-link">Supporting Information Figure S1</a>). These include E2F1, CEBPB, GATA3, Max, ELF1, GABP, and FOXA1 for <em>BRCA1</em> and E2F1, MYC, ELF1, GABP, Max, and PML for <em>BRCA2</em>. Interestingly, a number of these factors have previously been implicated in BC.</p>
<p>In addition, ENCODE ChIP‐seq data from cell lines derived from tissues other than breast indicate that the variants that affect protein binding are located within consensus motifs for specific TFs associated with these regions (Tables <a href="#humu23652-tbl-0002" class="usa-link">2</a> and <a href="#humu23652-tbl-0003" class="usa-link">3</a>; <a href="#humu23652-supl-0001" class="usa-link">Supporting Information Figure S1</a>). <em>BRCA1</em>:c.‐287C&gt;T overlaps with the consensus binding motif for CCAAT Box binding factors, <em>BRCA1</em>:c.‐315del is located in a consensus motif for CREB/ATF proteins, although the deletion does not modify this motif, and <em>BRCA2</em>:c.‐296C&gt;T is located within the consensus motif for PAX5. IT analysis also predicts that all these variants alter TF binding (Table <a href="#humu23652-tbl-0004" class="usa-link">4</a> and <a href="#humu23652-supl-0001" class="usa-link">Supporting Information Table S4</a>). We show that <em>BRCA1</em>:c.‐287C&gt;T disrupts the binding of NFYA to the <em>BRCA1</em> promoter region. Furthermore, we present evidence that <em>BRCA2</em>:c.‐296C&gt;T disrupts the binding of PAX5. <em>BRCA1</em>:c.‐315del lies in the so‐called positive regulator region that has been shown to bind GABPα, CREB, and AP‐1 proteins (Atlas et al., <a href="#humu23652-bib-0003" class="usa-link" aria-describedby="humu23652-bib-0003">2000</a>; Atlas, Stramwasser, &amp; Mueller, <a href="#humu23652-bib-0002" class="usa-link" aria-describedby="humu23652-bib-0002">2001</a>; Graves, Zhou, MacDonald, Mueller, &amp; Roskelley, <a href="#humu23652-bib-0021" class="usa-link" aria-describedby="humu23652-bib-0021">2007</a>; Suen &amp; Goss, <a href="#humu23652-bib-0053" class="usa-link" aria-describedby="humu23652-bib-0053">1999</a>; Thakur &amp; Croce, <a href="#humu23652-bib-0055" class="usa-link" aria-describedby="humu23652-bib-0055">1999</a>). Although these proteins are generally considered activators of transcription, repression of promoter activity by <em>BRCA1</em>:c.‐315del suggests the recruitment of an additional transcriptional repressor or corepressor to this region. IT analysis predicts creation of a binding site for POU2F2, a known repressor; however, we found no evidence to suggest that this variant increased POU2F2 binding in the cell line used, although it is possible that changes may be observable in other cell lines. Biochemical studies, including mass spectrometry, will be required to validate and discover other alterations in TF binding.</p>
<p>One variant, <em>BRCA1</em>:c.‐287C&gt;T, increased promoter activity and decreased protein:DNA interactions. This increase in promoter activity was unanticipated because this variant is within a consensus motif for the CCAAT box binding proteins, NFYA and NFYB, and mutation of this CCAAT box has previously been shown to reduce <em>BRCA1</em> promoter activity in MCF7 cells (Bindra et al., <a href="#humu23652-bib-0005" class="usa-link" aria-describedby="humu23652-bib-0005">2005</a>; Xu, Chambers, &amp; Solomon, <a href="#humu23652-bib-0060" class="usa-link" aria-describedby="humu23652-bib-0060">1997</a>). This variant also decreases promoter activity in MDA‐MB‐231 cells (Santana dos Santos et al., <a href="#humu23652-bib-0044" class="usa-link" aria-describedby="humu23652-bib-0044">2017</a>). Here, we show that the <em>BRCA1</em>:c.‐287C&gt;T variant reduces NFYA binding. Importantly, NFY proteins can function as transcriptional activators or repressors depending on recruitment of corepressors or coactivators (Peng &amp; Jahroudi, <a href="#humu23652-bib-0037" class="usa-link" aria-describedby="humu23652-bib-0037">2002</a>; Peng et al., <a href="#humu23652-bib-0038" class="usa-link" aria-describedby="humu23652-bib-0038">2007</a>) and recruitment of TFs to neighboring sequences (Zhu et al., <a href="#humu23652-bib-0061" class="usa-link" aria-describedby="humu23652-bib-0061">2012</a>) indicating possible mechanisms for divergent activities of NFY proteins at this site.</p>
<p>
<em>BRCA1</em>:c.‐192T&gt;C, which lies in the 5′UTR, decreased reporter activity but did not bind any proteins from MCF7 nuclear extracts in EMSA analysis. Possibly, EMSA binding conditions are not optimal for binding of factors to this sequence or alternatively, this reduction in promoter activity could be by posttranscriptional mechanisms as seen for <em>BRCA2</em>:c.‐26G&gt;A (Gochhait et al., <a href="#humu23652-bib-0020" class="usa-link" aria-describedby="humu23652-bib-0020">2007</a>).</p>
<p>Using existing prediction models developed for high risk variants, population frequency and clinical information classified 27 variants as "Not Pathogenic" or "likely Not Pathogenic." This included two <em>BRCA1</em> and six <em>BRCA2</em> variants with functional assay data available, six with no statistically significant effect on promoter activity, and two that decreased promoter activity in vitro. These two variants, <em>BRCA1:c</em>.‐192T&gt;C and <em>BRCA2:c</em>.‐296C&gt;T, were observed in population subgroup controls; notably <em>BRCA1:c</em>.‐192T&gt;C was observed at a frequency of &gt;1%, which is considered stand‐alone evidence against pathogenicity (defined as high risk of cancer) for <em>BRCA1/2</em> variation. This suggests that promoter region variants, irrespective of bioinformatic prediction or functional assay results, are unlikely to be associated with a high risk of cancer. This is consistent with current evidence from ENIGMA studies (de la Hoya et al., <a href="#humu23652-bib-0012" class="usa-link" aria-describedby="humu23652-bib-0012">2016</a>), which suggest that an allele resulting in only ∼20–30% expression of <em>BRCA1</em> transcript/s encoding functional transcripts is not associated with high risk of BC. The low impact of these variants on risk is likely to reflect the complex interplay of TFs and DNA elements, and possible redundancy in the system. For example, a variant in one TF binding site within a cluster may be buffered by other binding sites and thus insufficient on its own to reduce gene expression markedly (Lu &amp; Rogan, <a href="#humu23652-bib-0043" class="usa-link" aria-describedby="humu23652-bib-0043">2018</a>).</p>
<p>Given that moderate‐ and low‐risk variants often occur in &gt;1% of the population, and that the remaining 13 variants had insufficient evidence available to assess clinical significance, we cannot exclude the possibility that <em>BRCA1/2</em> promoter region variants, in particular those with proven functional effect, may be associated with a moderate or low risk of cancer. This indicates an urgent need to further develop prediction models to accommodate criteria for moderate‐ or low‐risk variants by extending the <em>BRCA1/2</em>‐specific criteria developed by ENIGMA (<a href="https://www.enigmaconsortium.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.enigmaconsortium.org/</a>), or even the generic variant classification criteria developed by the American College of Medical Genetics for Mendelian disorders (Richards et al., <a href="#humu23652-bib-0042" class="usa-link" aria-describedby="humu23652-bib-0042">2015</a>).</p>
<p>This study has evaluated the significance of single nucleotide variants and small indels mapping to the 5′ noncoding region of <em>BRCA1</em> and <em>BRCA2</em> using bioinformatic, biological, and biochemical analyses in combination with consideration of clinical data that inform qualitative and quantitative variant classification. We present data to suggest that a subset of these variants have functional effects on gene regulation. We also present evidence that variants mapping to and affecting the function of <em>BRCA</em> promoters are not likely to be associated with a high risk of cancer. We propose that studies of differing design, such as very large‐scale case‐control sequencing studies able to detect rare variation, will be required to address if a low to moderate risk of cancer may be associated with <em>BRCA1/2</em> regulatory region variation that has not been captured to date by genome‐wide association genotyping platforms. We believe that the bioinformatic and functional analysis presented will be important to define the design and interpretation of such future sequencing studies. We also believe that this study highlights the challenges associated with classifying variants with respect to low or moderate disease risk, and the need to be cautious in the clinical use of information on individual variants that is likely to be one of many factors contributing to disease risk.</p></section><section id="sec19"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="humu23652-supl-0001"><div class="caption p">
<p>Supplementary Figure S1. Variants in <em>BRCA1</em> and <em>BRCA2</em> overlap with potential TF binding sites. Snapshots of the UCSC genome browser showing <em>BRCA1</em> (A) and <em>BRCA2</em> (B) prioritized variants and ENCODE ChIP‐seq data from multiple cell lines and available breast cell specific TF ChIPseq data. TF consensus motifs within the ENCODE ChIP‐seq dataset tracks are displayed in green. Genomic position of variants that alter luciferase activity are indicated by vertical lines.</p>
<p>Supplementary Table S1. Oligonucleotides used in this study</p>
<p>Supplementary Table S2. Overview of rare variants in the <em>BRCA1</em> 5'upstream region in patients and controls.*</p>
<p>Supplementary Table S3. Overview of rare variants in the <em>BRCA2</em> 5'upstream region in patients and controls.*</p>
<p>Supplementary Table S4. Information Theory Analysis of Prioritized Variants</p>
<p>Supplementary Table S5. Clinical classification of <em>BRCA1</em> and <em>BRCA2</em> 5' noncoding variants</p>
<p>Supplementary Table S6. Tumour histopathology status for <em>BRCA1</em> and <em>BRCA2</em> 5' noncoding variants</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/6282814/bin/HUMU-39-2025-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (606.9KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="humu23652-supl-0002"><div class="caption p"><p>Supplementary methods</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/6282814/bin/HUMU-39-2025-s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (101.6KB, pdf) </sup>
</div></div></section></section><section id="humu23652-sec-0190" class="ack"><h2 class="pmc_sec_title">ACKNOWLEDGEMENTS</h2>
<p>The authors would like to acknowledge all the patients that were involved in this study. This work was supported by grants from the National Health and Medical Research Council (ID1104808) and Cancer Council Queensland (ID1044008 and ID1026095) to M.A.B. A.B.S. is supported by an NHMRC Senior Research Fellowship (ID1061779). S.L.E. is supported by an NHMRC Senior Research Fellowship (ID1135932). This work was supported by the grants from the National Cancer Institute (INCa: INCA‐DGOS_8706 to S.M.C.), the Ministry of Health of the Czech Republic (AZV 16–33444A: J.Sevcik, J.S., M.J., P.Z., K.L., L.S., and M.B), and Fondazione Pisa (G. G. and M. C. #2016), the Spanish Instituto de Salud Carlos III (ISCIII) funding (to O.D and S.O.G), an initiative of the Spanish Ministry of Economy and Innovation and partially supported by European Regional Development FEDER Funds: FIS PI12/02585 and PI15/00355 (to O.D.) and PI13/01711 and PI16/01218 (to S.G‐E.). S.G‐E. is supported by the Miguel Servet Progam (CP10/00617). Partial funding also came from a CIBERER grant (ER17P1AC7112/2017) and Fundación Mutua Madrileña to A.V. and a Ghent University Special Research Fund (BOF15/GOA/011) to K.B.M.C. P.K.R. is supported by the Canadian Breast Cancer Foundation, Canadian Foundation for Innovation, Canada Research Chairs Secretariat, and the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery Grant RGPIN‐2015‐06290). T.vO.H and M.R. were supported by The Research Council of The Capital Region of Denmark (Grant E‐22283‐02). P.P. and P.R. were supported by Investigator Grants (#4017 to P.P. and #15547 to P.R.) from the Italian Association for Cancer Research (AIRC).</p></section><section id="humu23652-sec-0200" class="ack"><h2 class="pmc_sec_title">DISCLOSURE STATEMENT</h2>
<p>B.C.S is an employee of and P.K.R is co‐founder of CytoGnomix, which has developed algorithms and software for interpretation of variants within transcription factor binding sites.</p></section><section id="notes1"><p>

Burke LJ, Sevcik J, Gambino G, et al. 
<em>BRCA1</em> and <em>BRCA2</em> 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding. Human Mutation. 2018;39:2025–2039. 10.1002/humu.23652

</p>
<section id="fn-group1" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="humu23652-note-0002"><p>Communicated by Peter J. Oefner</p></div></div></section></section><section id="humu23652-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">REFERENCES</h2>
<section id="humu23652-bibl-0001_sec2"><ol class="ref-list font-sm">
<li id="humu23652-bib-0001">
<cite>

Amendola, L. M.
, 
Dorschner, M. O.
, 
Robertson, P. D.
, 
Salama, J. S.
, 
Hart, R.
, 
Shirts, B. H.
, … 
Jarvik, G. P.
 (2015). Actionable exomic incidental findings in 6503 participants: Challenges of variant classification. Genome Research, 25(3), 305–315. 10.1101/gr.183483.114
</cite> [<a href="https://doi.org/10.1101/gr.183483.114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4352885/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25637381/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Research&amp;title=Actionable%20exomic%20incidental%20findings%20in%206503%20participants:%20Challenges%20of%20variant%20classification&amp;author=L.%20M.%20Amendola&amp;author=M.%20O.%20Dorschner&amp;author=P.%20D.%20Robertson&amp;author=J.%20S.%20Salama&amp;author=R.%20Hart&amp;volume=25&amp;issue=3&amp;publication_year=2015&amp;pages=305-315&amp;pmid=25637381&amp;doi=10.1101/gr.183483.114&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0002">
<cite>

Atlas, E.
, 
Stramwasser, M.
, &amp; 
Mueller, C. R.
 (2001). A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element. Oncogene, 20(48), 7110–7114. 10.1038/sj.onc.1204890
</cite> [<a href="https://doi.org/10.1038/sj.onc.1204890" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11704836/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=A%20CREB%20site%20in%20the%20BRCA1%20proximal%20promoter%20acts%20as%20a%20constitutive%20transcriptional%20element&amp;author=E.%20Atlas&amp;author=M.%20Stramwasser&amp;author=C.%20R.%20Mueller&amp;volume=20&amp;issue=48&amp;publication_year=2001&amp;pages=7110-7114&amp;pmid=11704836&amp;doi=10.1038/sj.onc.1204890&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0003">
<cite>

Atlas, E.
, 
Stramwasser, M.
, 
Whiskin, K.
, &amp; 
Mueller, C. R.
 (2000). GA‐binding protein alpha/beta is a critical regulator of the BRCA1 promoter. Oncogene, 19(15), 1933–1940. 10.1038/sj.onc.1203516
</cite> [<a href="https://doi.org/10.1038/sj.onc.1203516" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10773883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=GA%E2%80%90binding%20protein%20alpha/beta%20is%20a%20critical%20regulator%20of%20the%20BRCA1%20promoter&amp;author=E.%20Atlas&amp;author=M.%20Stramwasser&amp;author=K.%20Whiskin&amp;author=C.%20R.%20Mueller&amp;volume=19&amp;issue=15&amp;publication_year=2000&amp;pages=1933-1940&amp;pmid=10773883&amp;doi=10.1038/sj.onc.1203516&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0004">
<cite>

Betts, J. A.
, 
French, J. D.
, 
Brown, M. A.
, &amp; 
Edwards, S. L.
 (2013). Long‐range transcriptional regulation of breast cancer genes. Genes, Chromosomes and Cancer, 52(2), 113–125. 10.1002/gcc.22020
</cite> [<a href="https://doi.org/10.1002/gcc.22020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23077082/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes,%20Chromosomes%20and%20Cancer&amp;title=Long%E2%80%90range%20transcriptional%20regulation%20of%20breast%20cancer%20genes&amp;author=J.%20A.%20Betts&amp;author=J.%20D.%20French&amp;author=M.%20A.%20Brown&amp;author=S.%20L.%20Edwards&amp;volume=52&amp;issue=2&amp;publication_year=2013&amp;pages=113-125&amp;pmid=23077082&amp;doi=10.1002/gcc.22020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0005">
<cite>

Bindra, R. S.
, 
Gibson, S. L.
, 
Meng, A.
, 
Westermark, U.
, 
Jasin, M.
, 
Pierce, A. J.
, … 
Glazer, P. M.
 (2005). Hypoxia‐induced down‐regulation of BRCA1 expression by E2Fs. Cancer Research, 65(24), 11597–11604. 10.1158/0008-5472.CAN-05-2119
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-05-2119" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16357170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Research&amp;title=Hypoxia%E2%80%90induced%20down%E2%80%90regulation%20of%20BRCA1%20expression%20by%20E2Fs&amp;author=R.%20S.%20Bindra&amp;author=S.%20L.%20Gibson&amp;author=A.%20Meng&amp;author=U.%20Westermark&amp;author=M.%20Jasin&amp;volume=65&amp;issue=24&amp;publication_year=2005&amp;pages=11597-11604&amp;pmid=16357170&amp;doi=10.1158/0008-5472.CAN-05-2119&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0006">
<cite>

Bogdanova, N.
, 
Helbig, S.
, &amp; 
Dork, T.
 (2013). Hereditary breast cancer: Ever more pieces to the polygenic puzzle. Hereditary Cancer in Clinical Practice, 11(1), 12
10.1186/1897-4287-11-12
</cite> [<a href="https://doi.org/10.1186/1897-4287-11-12" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3851033/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24025454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hereditary%20Cancer%20in%20Clinical%20Practice&amp;title=Hereditary%20breast%20cancer:%20Ever%20more%20pieces%20to%20the%20polygenic%20puzzle&amp;author=N.%20Bogdanova&amp;author=S.%20Helbig&amp;author=T.%20Dork&amp;volume=11&amp;issue=1&amp;publication_year=2013&amp;pages=12&amp;pmid=24025454&amp;doi=10.1186/1897-4287-11-12&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0007">
<cite>

Brewster, B. L.
, 
Rossiello, F.
, 
French, J. D.
, 
Edwards, S. L.
, 
Wong, M.
, 
Wronski, A.
, … 
Peterlongo, P.
 (2012). Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR‐103 target site. Human Mutation, 33(12), 1665–1675. 10.1002/humu.22159
</cite> [<a href="https://doi.org/10.1002/humu.22159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22753153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Human%20Mutation&amp;title=Identification%20of%20fifteen%20novel%20germline%20variants%20in%20the%20BRCA1%203'UTR%20reveals%20a%20variant%20in%20a%20breast%20cancer%20case%20that%20introduces%20a%20functional%20miR%E2%80%90103%20target%20site&amp;author=B.%20L.%20Brewster&amp;author=F.%20Rossiello&amp;author=J.%20D.%20French&amp;author=S.%20L.%20Edwards&amp;author=M.%20Wong&amp;volume=33&amp;issue=12&amp;publication_year=2012&amp;pages=1665-1675&amp;pmid=22753153&amp;doi=10.1002/humu.22159&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0008">
<cite>

Brown, M. A.
, 
Lo, L. J.
, 
Catteau, A.
, 
Xu, C. F.
, 
Lindeman, G. J.
, 
Hodgson, S.
, &amp; 
Solomon, E.
 (2002). Germline BRCA1 promoter deletions in UK and Australian familial breast cancer patients: Identification of a novel deletion consistent with BRCA1:pSiBRCA1 recombination. Human Mutation, 19(4), 435–442. 10.1002/humu.10055
</cite> [<a href="https://doi.org/10.1002/humu.10055" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11933198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Human%20Mutation&amp;title=Germline%20BRCA1%20promoter%20deletions%20in%20UK%20and%20Australian%20familial%20breast%20cancer%20patients:%20Identification%20of%20a%20novel%20deletion%20consistent%20with%20BRCA1:pSiBRCA1%20recombination&amp;author=M.%20A.%20Brown&amp;author=L.%20J.%20Lo&amp;author=A.%20Catteau&amp;author=C.%20F.%20Xu&amp;author=G.%20J.%20Lindeman&amp;volume=19&amp;issue=4&amp;publication_year=2002&amp;pages=435-442&amp;pmid=11933198&amp;doi=10.1002/humu.10055&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0009">
<cite>

Caminsky, N. G.
, 
Mucaki, E. J.
, 
Perri, A. M.
, 
Lu, R.
, 
Knoll, J. H.
, &amp; 
Rogan, P. K.
 (2016). Prioritizing variants in complete hereditary breast and ovarian cancer genes in patients lacking known BRCA mutations. Human Mutation, 37(7), 640–652. 10.1002/humu.22972
</cite> [<a href="https://doi.org/10.1002/humu.22972" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26898890/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Human%20Mutation&amp;title=Prioritizing%20variants%20in%20complete%20hereditary%20breast%20and%20ovarian%20cancer%20genes%20in%20patients%20lacking%20known%20BRCA%20mutations&amp;author=N.%20G.%20Caminsky&amp;author=E.%20J.%20Mucaki&amp;author=A.%20M.%20Perri&amp;author=R.%20Lu&amp;author=J.%20H.%20Knoll&amp;volume=37&amp;issue=7&amp;publication_year=2016&amp;pages=640-652&amp;pmid=26898890&amp;doi=10.1002/humu.22972&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0010">
<cite>

Couch, F. J.
, 
Shimelis, H.
, 
Hu, C.
, 
Hart, S. N.
, 
Polley, E. C.
, 
Na, J.
, … 
Dolinsky, J. S.
 (2017). Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncology, 3(9), 1190–1196. 10.1001/jamaoncol.2017.0424
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2017.0424" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5599323/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28418444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncology&amp;title=Associations%20between%20cancer%20predisposition%20testing%20panel%20genes%20and%20breast%20cancer&amp;author=F.%20J.%20Couch&amp;author=H.%20Shimelis&amp;author=C.%20Hu&amp;author=S.%20N.%20Hart&amp;author=E.%20C.%20Polley&amp;volume=3&amp;issue=9&amp;publication_year=2017&amp;pages=1190-1196&amp;pmid=28418444&amp;doi=10.1001/jamaoncol.2017.0424&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0011">
<cite>

Davis, P. L.
, 
Miron, A.
, 
Andersen, L. M.
, 
Iglehart, J. D.
, &amp; 
Marks, J. R.
 (1999). Isolation and initial characterization of the BRCA2 promoter. Oncogene, 18(44), 6000–6012. 10.1038/sj.onc.1202990
</cite> [<a href="https://doi.org/10.1038/sj.onc.1202990" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10557089/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Isolation%20and%20initial%20characterization%20of%20the%20BRCA2%20promoter&amp;author=P.%20L.%20Davis&amp;author=A.%20Miron&amp;author=L.%20M.%20Andersen&amp;author=J.%20D.%20Iglehart&amp;author=J.%20R.%20Marks&amp;volume=18&amp;issue=44&amp;publication_year=1999&amp;pages=6000-6012&amp;pmid=10557089&amp;doi=10.1038/sj.onc.1202990&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0012">
<cite>

de la Hoya, M.
, 
Soukarieh, O.
, 
Lopez‐Perolio, I.
, 
Vega, A.
, 
Walker, L. C.
, 
van Ierland, Y.
, … 
Spurdle, A. B.
 (2016). Combined genetic and splicing analysis of BRCA1 c.[594‐2A&gt;C; 641A&gt;G] highlights the relevance of naturally occurring in‐frame transcripts for developing disease gene variant classification algorithms. Human Molecular Genetics, 25(11), 2256–2268. 10.1093/hmg/ddw094
</cite> [<a href="https://doi.org/10.1093/hmg/ddw094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5081057/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27008870/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Human%20Molecular%20Genetics&amp;title=Combined%20genetic%20and%20splicing%20analysis%20of%20BRCA1%20c.%5B594%E2%80%902A&gt;C;%20641A&gt;G%5D%20highlights%20the%20relevance%20of%20naturally%20occurring%20in%E2%80%90frame%20transcripts%20for%20developing%20disease%20gene%20variant%20classification%20algorithms&amp;author=M.%20de%20la%20Hoya&amp;author=O.%20Soukarieh&amp;author=I.%20Lopez%E2%80%90Perolio&amp;author=A.%20Vega&amp;author=L.%20C.%20Walker&amp;volume=25&amp;issue=11&amp;publication_year=2016&amp;pages=2256-2268&amp;pmid=27008870&amp;doi=10.1093/hmg/ddw094&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0013">
<cite>

Diederichs, S.
, 
Bartsch, L.
, 
Berkmann, J. C.
, 
Frose, K.
, 
Heitmann, J.
, 
Hoppe, C.
, … 
Wullenkord, R.
 (2016). The dark matter of the cancer genome: Aberrations in regulatory elements, untranslated regions, splice sites, non‐coding RNA and synonymous mutations. EMBO Molecular Medicine, 8(5), 442–457. 10.15252/emmm.201506055
</cite> [<a href="https://doi.org/10.15252/emmm.201506055" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5126213/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26992833/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EMBO%20Molecular%20Medicine&amp;title=The%20dark%20matter%20of%20the%20cancer%20genome:%20Aberrations%20in%20regulatory%20elements,%20untranslated%20regions,%20splice%20sites,%20non%E2%80%90coding%20RNA%20and%20synonymous%20mutations&amp;author=S.%20Diederichs&amp;author=L.%20Bartsch&amp;author=J.%20C.%20Berkmann&amp;author=K.%20Frose&amp;author=J.%20Heitmann&amp;volume=8&amp;issue=5&amp;publication_year=2016&amp;pages=442-457&amp;pmid=26992833&amp;doi=10.15252/emmm.201506055&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0014">
<cite>

Ding, Y. C.
, 
McGuffog, L.
, 
Healey, S.
, 
Friedman, E.
, 
Laitman, Y.
, &amp; 
Paluch‐Shimon, S.
, … Consortium of Investigators of Modifiers of, B
. (2012). A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers &amp; Prevention, 21(8), 1362–1370. 10.1158/1055-9965.EPI-12-0229
</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-12-0229" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3415567/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22729394/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiology,%20Biomarkers%20&amp;%20Prevention&amp;title=A%20nonsynonymous%20polymorphism%20in%20IRS1%20modifies%20risk%20of%20developing%20breast%20and%20ovarian%20cancers%20in%20BRCA1%20and%20ovarian%20cancer%20in%20BRCA2%20mutation%20carriers&amp;author=Y.%20C.%20Ding&amp;author=L.%20McGuffog&amp;author=S.%20Healey&amp;author=E.%20Friedman&amp;author=Y.%20Laitman&amp;volume=21&amp;issue=8&amp;publication_year=2012&amp;pages=1362-1370&amp;pmid=22729394&amp;doi=10.1158/1055-9965.EPI-12-0229&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0015">
<cite>

Eccles, S. A.
, 
Aboagye, E. O.
, 
Ali, S.
, 
Anderson, A. S.
, 
Armes, J.
, 
Berditchevski, F.
, … 
Thompson, A. M.
 (2013). Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Research, 15(5), R92
10.1186/bcr3493
</cite> [<a href="https://doi.org/10.1186/bcr3493" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3907091/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24286369/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Research&amp;title=Critical%20research%20gaps%20and%20translational%20priorities%20for%20the%20successful%20prevention%20and%20treatment%20of%20breast%20cancer&amp;author=S.%20A.%20Eccles&amp;author=E.%20O.%20Aboagye&amp;author=S.%20Ali&amp;author=A.%20S.%20Anderson&amp;author=J.%20Armes&amp;volume=15&amp;issue=5&amp;publication_year=2013&amp;pages=R92&amp;pmid=24286369&amp;doi=10.1186/bcr3493&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0016">
<cite>

Evans, D. G. R.
, 
van Veen, E. M.
, 
Byers, H. J.
, 
Wallace, A. J.
, 
Ellingford, J. M.
, 
Beaman, G.
, … 
Newman, W. G.
 (2018). A dominantly inherited 5' UTR variant causing methylation‐associated silencing of BRCA1 as a cause of breast and ovarian cancer. American Journal of Human Genetics, 103(2), 213–220. 10.1016/j.ajhg.2018.07.002
</cite> [<a href="https://doi.org/10.1016/j.ajhg.2018.07.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6080768/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30075112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Human%20Genetics&amp;title=A%20dominantly%20inherited%205'%20UTR%20variant%20causing%20methylation%E2%80%90associated%20silencing%20of%20BRCA1%20as%20a%20cause%20of%20breast%20and%20ovarian%20cancer&amp;author=D.%20G.%20R.%20Evans&amp;author=E.%20M.%20van%20Veen&amp;author=H.%20J.%20Byers&amp;author=A.%20J.%20Wallace&amp;author=J.%20M.%20Ellingford&amp;volume=103&amp;issue=2&amp;publication_year=2018&amp;pages=213-220&amp;pmid=30075112&amp;doi=10.1016/j.ajhg.2018.07.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0017">
<cite>

Fraile‐Bethencourt, E.
, 
Valenzuela‐Palomo, A.
, 
Diez‐Gomez, B.
, 
Infante, M.
, 
Duran, M.
, 
Marcos, G.
, … 
Velasco, E. A.
 (2018). Genetic dissection of the BRCA2 promoter and transcriptional impact of DNA variants. Breast Cancer Research and Treatment. 10.1007/s10549-018-4826-7
</cite> [<a href="https://doi.org/10.1007/s10549-018-4826-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29766361/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Research%20and%20Treatment&amp;title=Genetic%20dissection%20of%20the%20BRCA2%20promoter%20and%20transcriptional%20impact%20of%20DNA%20variants&amp;author=E.%20Fraile%E2%80%90Bethencourt&amp;author=A.%20Valenzuela%E2%80%90Palomo&amp;author=B.%20Diez%E2%80%90Gomez&amp;author=M.%20Infante&amp;author=M.%20Duran&amp;publication_year=2018&amp;pmid=29766361&amp;doi=10.1007/s10549-018-4826-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0018">
<cite>

French, J. D.
, 
Ghoussaini, M.
, 
Edwards, S. L.
, 
Meyer, K. B.
, 
Michailidou, K.
, 
Ahmed, S.
, … 
Dunning, A. M.
 (2013). Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long‐range enhancers. American Journal of Human Genetics, 92(4), 489–503. 10.1016/j.ajhg.2013.01.002
</cite> [<a href="https://doi.org/10.1016/j.ajhg.2013.01.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3617380/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23540573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Human%20Genetics&amp;title=Functional%20variants%20at%20the%2011q13%20risk%20locus%20for%20breast%20cancer%20regulate%20cyclin%20D1%20expression%20through%20long%E2%80%90range%20enhancers&amp;author=J.%20D.%20French&amp;author=M.%20Ghoussaini&amp;author=S.%20L.%20Edwards&amp;author=K.%20B.%20Meyer&amp;author=K.%20Michailidou&amp;volume=92&amp;issue=4&amp;publication_year=2013&amp;pages=489-503&amp;pmid=23540573&amp;doi=10.1016/j.ajhg.2013.01.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0019">
<cite>

Ghoussaini, M.
, 
Pharoah, P. D. P.
, &amp; 
Easton, D. F.
 (2013). Inherited genetic susceptibility to breast cancer: The beginning of the end or the end of the beginning?
The American Journal of Pathology, 183(4), 1038–1051. 10.1016/j.ajpath.2013.07.003
</cite> [<a href="https://doi.org/10.1016/j.ajpath.2013.07.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23973388/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20American%20Journal%20of%20Pathology&amp;title=Inherited%20genetic%20susceptibility%20to%20breast%20cancer:%20The%20beginning%20of%20the%20end%20or%20the%20end%20of%20the%20beginning?&amp;author=M.%20Ghoussaini&amp;author=P.%20D.%20P.%20Pharoah&amp;author=D.%20F.%20Easton&amp;volume=183&amp;issue=4&amp;publication_year=2013&amp;pages=1038-1051&amp;pmid=23973388&amp;doi=10.1016/j.ajpath.2013.07.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0020">
<cite>

Gochhait, S.
, 
Bukhari, S. I.
, 
Bairwa, N.
, 
Vadhera, S.
, 
Darvishi, K.
, 
Raish, M.
, … 
Bamezai, R. N.
 (2007). Implication of BRCA2 ‐26G&gt;A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg&gt;Pro polymorphism. Breast Cancer Research, 9(5), R71
10.1186/bcr1780
</cite> [<a href="https://doi.org/10.1186/bcr1780" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2242669/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17945002/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Research&amp;title=Implication%20of%20BRCA2%20%E2%80%9026G&gt;A%205'%20untranslated%20region%20polymorphism%20in%20susceptibility%20to%20sporadic%20breast%20cancer%20and%20its%20modulation%20by%20p53%20codon%2072%20Arg&gt;Pro%20polymorphism&amp;author=S.%20Gochhait&amp;author=S.%20I.%20Bukhari&amp;author=N.%20Bairwa&amp;author=S.%20Vadhera&amp;author=K.%20Darvishi&amp;volume=9&amp;issue=5&amp;publication_year=2007&amp;pages=R71&amp;pmid=17945002&amp;doi=10.1186/bcr1780&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0021">
<cite>

Graves, M. L.
, 
Zhou, L.
, 
MacDonald, G.
, 
Mueller, C. R.
, &amp; 
Roskelley, C. D.
 (2007). Regulation of the BRCA1 promoter in ovarian surface epithelial cells and ovarian carcinoma cells. FEBS Letters, 581(9), 1825–1833. 10.1016/j.febslet.2007.03.072
</cite> [<a href="https://doi.org/10.1016/j.febslet.2007.03.072" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17434164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Letters&amp;title=Regulation%20of%20the%20BRCA1%20promoter%20in%20ovarian%20surface%20epithelial%20cells%20and%20ovarian%20carcinoma%20cells&amp;author=M.%20L.%20Graves&amp;author=L.%20Zhou&amp;author=G.%20MacDonald&amp;author=C.%20R.%20Mueller&amp;author=C.%20D.%20Roskelley&amp;volume=581&amp;issue=9&amp;publication_year=2007&amp;pages=1825-1833&amp;pmid=17434164&amp;doi=10.1016/j.febslet.2007.03.072&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0022">
<cite>

Heikkinen, T.
, 
Greco, D.
, 
Pelttari, L. M.
, 
Tommiska, J.
, 
Vahteristo, P.
, 
Heikkila, P.
, … 
Nevanlinna, H.
 (2011). Variants on the promoter region of PTEN affect breast cancer progression and patient survival. Breast Cancer Research, 13(6), R130
10.1186/bcr3076
</cite> [<a href="https://doi.org/10.1186/bcr3076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3326572/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22171747/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Research&amp;title=Variants%20on%20the%20promoter%20region%20of%20PTEN%20affect%20breast%20cancer%20progression%20and%20patient%20survival&amp;author=T.%20Heikkinen&amp;author=D.%20Greco&amp;author=L.%20M.%20Pelttari&amp;author=J.%20Tommiska&amp;author=P.%20Vahteristo&amp;volume=13&amp;issue=6&amp;publication_year=2011&amp;pages=R130&amp;pmid=22171747&amp;doi=10.1186/bcr3076&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0023">
<cite>

Hitchins, M. P.
, 
Rapkins, R. W.
, 
Kwok, C. T.
, 
Srivastava, S.
, 
Wong, J. J.
, 
Khachigian, L. M.
, … 
Ward, R. L.
 (2011). Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer‐affected family is linked to a single nucleotide variant within the 5'UTR. Cancer Cell, 20(2), 200–213. 10.1016/j.ccr.2011.07.003
</cite> [<a href="https://doi.org/10.1016/j.ccr.2011.07.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21840485/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Dominantly%20inherited%20constitutional%20epigenetic%20silencing%20of%20MLH1%20in%20a%20cancer%E2%80%90affected%20family%20is%20linked%20to%20a%20single%20nucleotide%20variant%20within%20the%205'UTR&amp;author=M.%20P.%20Hitchins&amp;author=R.%20W.%20Rapkins&amp;author=C.%20T.%20Kwok&amp;author=S.%20Srivastava&amp;author=J.%20J.%20Wong&amp;volume=20&amp;issue=2&amp;publication_year=2011&amp;pages=200-213&amp;pmid=21840485&amp;doi=10.1016/j.ccr.2011.07.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0024">
<cite>

Horn, S.
, 
Figl, A.
, 
Rachakonda, P. S.
, 
Fischer, C.
, 
Sucker, A.
, 
Gast, A.
, … 
Kumar, R.
 (2013). TERT promoter mutations in familial and sporadic melanoma. Science, 339(6122), 959–961. 10.1126/science.1230062
</cite> [<a href="https://doi.org/10.1126/science.1230062" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23348503/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=TERT%20promoter%20mutations%20in%20familial%20and%20sporadic%20melanoma&amp;author=S.%20Horn&amp;author=A.%20Figl&amp;author=P.%20S.%20Rachakonda&amp;author=C.%20Fischer&amp;author=A.%20Sucker&amp;volume=339&amp;issue=6122&amp;publication_year=2013&amp;pages=959-961&amp;pmid=23348503&amp;doi=10.1126/science.1230062&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0025">
<cite>

Kao, J.
, 
Salari, K.
, 
Bocanegra, M.
, 
Choi, Y. L.
, 
Girard, L.
, 
Gandhi, J.
, … 
Pollack, J. R.
 (2009). Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One, 4(7), e6146
10.1371/journal.pone.0006146
</cite> [<a href="https://doi.org/10.1371/journal.pone.0006146" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2702084/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19582160/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Molecular%20profiling%20of%20breast%20cancer%20cell%20lines%20defines%20relevant%20tumor%20models%20and%20provides%20a%20resource%20for%20cancer%20gene%20discovery&amp;author=J.%20Kao&amp;author=K.%20Salari&amp;author=M.%20Bocanegra&amp;author=Y.%20L.%20Choi&amp;author=L.%20Girard&amp;volume=4&amp;issue=7&amp;publication_year=2009&amp;pages=e6146&amp;pmid=19582160&amp;doi=10.1371/journal.pone.0006146&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0026">
<cite>

Kozmik, Z.
, 
Wang, S.
, 
Dorfler, P.
, 
Adams, B.
, &amp; 
Busslinger, M.
 (1992). The promoter of the CD19 gene is a target for the B‐cell‐specific transcription factor BSAP. Molecular and Cellular Biology, 12(6), 2662–2672.</cite> [<a href="https://doi.org/10.1128/mcb.12.6.2662" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC364460/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1375324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20and%20Cellular%20Biology&amp;title=The%20promoter%20of%20the%20CD19%20gene%20is%20a%20target%20for%20the%20B%E2%80%90cell%E2%80%90specific%20transcription%20factor%20BSAP&amp;author=Z.%20Kozmik&amp;author=S.%20Wang&amp;author=P.%20Dorfler&amp;author=B.%20Adams&amp;author=M.%20Busslinger&amp;volume=12&amp;issue=6&amp;publication_year=1992&amp;pages=2662-2672&amp;pmid=1375324&amp;doi=10.1128/mcb.12.6.2662&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0027">
<cite>

Kuchenbaecker, K. B.
, 
McGuffog, L.
, 
Barrowdale, D.
, 
Lee, A.
, 
Soucy, P.
, 
Dennis, J.
, … 
Antoniou, A. C.
 (2017). Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute, 109(7). 10.1093/jnci/djw302
</cite> [<a href="https://doi.org/10.1093/jnci/djw302" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5408990/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28376175/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20National%20Cancer%20Institute&amp;title=Evaluation%20of%20polygenic%20risk%20scores%20for%20breast%20and%20ovarian%20cancer%20risk%20prediction%20in%20BRCA1%20and%20BRCA2%20mutation%20carriers&amp;author=K.%20B.%20Kuchenbaecker&amp;author=L.%20McGuffog&amp;author=D.%20Barrowdale&amp;author=A.%20Lee&amp;author=P.%20Soucy&amp;volume=109&amp;issue=7&amp;publication_year=2017&amp;pmid=28376175&amp;doi=10.1093/jnci/djw302&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0028">
<cite>

Lhota, F.
, 
Zemankova, P.
, 
Kleiblova, P.
, 
Soukupova, J.
, 
Vocka, M.
, 
Stranecky, V.
, … 
Kleibl, Z.
 (2016). Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2‐negatively tested breast cancer patients. Clinical Genetics, 90(4), 324–333. 10.1111/cge.12748
</cite> [<a href="https://doi.org/10.1111/cge.12748" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26822949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Genetics&amp;title=Hereditary%20truncating%20mutations%20of%20DNA%20repair%20and%20other%20genes%20in%20BRCA1/BRCA2/PALB2%E2%80%90negatively%20tested%20breast%20cancer%20patients&amp;author=F.%20Lhota&amp;author=P.%20Zemankova&amp;author=P.%20Kleiblova&amp;author=J.%20Soukupova&amp;author=M.%20Vocka&amp;volume=90&amp;issue=4&amp;publication_year=2016&amp;pages=324-333&amp;pmid=26822949&amp;doi=10.1111/cge.12748&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0043">
<cite>

Lu, R.
, &amp; 
Rogan, P. K.
 (2018). Information‐dense transcription factor binding site clusters identify target genes with similar tissue‐wide expression profiles and serve as a buffer against mutations. bioRxiv. 10.1101/283267
</cite> [<a href="https://doi.org/10.1101/283267" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6464064/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31001412/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=bioRxiv&amp;title=Information%E2%80%90dense%20transcription%20factor%20binding%20site%20clusters%20identify%20target%20genes%20with%20similar%20tissue%E2%80%90wide%20expression%20profiles%20and%20serve%20as%20a%20buffer%20against%20mutations&amp;author=R.%20Lu&amp;author=P.%20K.%20Rogan&amp;publication_year=2018&amp;pmid=31001412&amp;doi=10.1101/283267&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0029">
<cite>

Lu, R.
, 
Mucaki, E. J.
, &amp; 
Rogan, P. K.
 (2017). Discovery and validation of information theory‐based transcription factor and cofactor binding site motifs. Nucleic Acids Research, 45(5), e27
10.1093/nar/gkw1036
</cite> [<a href="https://doi.org/10.1093/nar/gkw1036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5389469/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27899659/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Research&amp;title=Discovery%20and%20validation%20of%20information%20theory%E2%80%90based%20transcription%20factor%20and%20cofactor%20binding%20site%20motifs&amp;author=R.%20Lu&amp;author=E.%20J.%20Mucaki&amp;author=P.%20K.%20Rogan&amp;volume=45&amp;issue=5&amp;publication_year=2017&amp;pages=e27&amp;pmid=27899659&amp;doi=10.1093/nar/gkw1036&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0030">
<cite>

Manolio, T. A.
, 
Collins, F. S.
, 
Cox, N. J.
, 
Goldstein, D. B.
, 
Hindorff, L. A.
, 
Hunter, D. J.
, … 
Visscher, P. M.
 (2009). Finding the missing heritability of complex diseases. Nature, 461(7265), 747–753. 10.1038/nature08494
</cite> [<a href="https://doi.org/10.1038/nature08494" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2831613/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19812666/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Finding%20the%20missing%20heritability%20of%20complex%20diseases&amp;author=T.%20A.%20Manolio&amp;author=F.%20S.%20Collins&amp;author=N.%20J.%20Cox&amp;author=D.%20B.%20Goldstein&amp;author=L.%20A.%20Hindorff&amp;volume=461&amp;issue=7265&amp;publication_year=2009&amp;pages=747-753&amp;pmid=19812666&amp;doi=10.1038/nature08494&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0031">
<cite>

McCoy, M. L.
, 
Mueller, C. R.
, &amp; 
Roskelley, C. D.
 (2003). The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer. Reproductive Biology and Endocrinology, 1, 72
10.1186/1477-7827-1-72
</cite> [<a href="https://doi.org/10.1186/1477-7827-1-72" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC270004/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14613551/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Reproductive%20Biology%20and%20Endocrinology&amp;title=The%20role%20of%20the%20breast%20cancer%20susceptibility%20gene%201%20(BRCA1)%20in%20sporadic%20epithelial%20ovarian%20cancer&amp;author=M.%20L.%20McCoy&amp;author=C.%20R.%20Mueller&amp;author=C.%20D.%20Roskelley&amp;volume=1&amp;publication_year=2003&amp;pages=72&amp;pmid=14613551&amp;doi=10.1186/1477-7827-1-72&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0032">
<cite>

Michailidou, K.
, 
Lindstrom, S.
, 
Dennis, J.
, 
Beesley, J.
, 
Hui, S.
, 
Kar, S.
, … 
Easton, D. F.
 (2017). Association analysis identifies 65 new breast cancer risk loci. Nature, 551(7678), 92–94. 10.1038/nature24284
</cite> [<a href="https://doi.org/10.1038/nature24284" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5798588/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29059683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Association%20analysis%20identifies%2065%20new%20breast%20cancer%20risk%20loci&amp;author=K.%20Michailidou&amp;author=S.%20Lindstrom&amp;author=J.%20Dennis&amp;author=J.%20Beesley&amp;author=S.%20Hui&amp;volume=551&amp;issue=7678&amp;publication_year=2017&amp;pages=92-94&amp;pmid=29059683&amp;doi=10.1038/nature24284&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0033">
<cite>

Millot, G. A.
, 
Carvalho, M. A.
, 
Caputo, S. M.
, 
Vreeswijk, M. P.
, 
Brown, M. A.
, 
Webb, M.
, … Group, E. C. F. A. W.
(2012). A guide for functional analysis of BRCA1 variants of uncertain significance. Human Mutation, 33(11), 1526–1537. 10.1002/humu.22150
</cite> [<a href="https://doi.org/10.1002/humu.22150" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3470782/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22753008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Human%20Mutation&amp;title=A%20guide%20for%20functional%20analysis%20of%20BRCA1%20variants%20of%20uncertain%20significance&amp;author=G.%20A.%20Millot&amp;author=M.%20A.%20Carvalho&amp;author=S.%20M.%20Caputo&amp;author=M.%20P.%20Vreeswijk&amp;author=M.%20A.%20Brown&amp;volume=33&amp;issue=11&amp;publication_year=2012&amp;pages=1526-1537&amp;pmid=22753008&amp;doi=10.1002/humu.22150&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0034">
<cite>

Mucaki, E. J.
, 
Caminsky, N. G.
, 
Perri, A. M.
, 
Lu, R.
, 
Laederach, A.
, 
Halvorsen, M.
, … 
Rogan, P. K.
 (2016). A unified analytic framework for prioritization of non‐coding variants of uncertain significance in heritable breast and ovarian cancer. BMC Medical Genomics, 9, 19
10.1186/s12920-016-0178-5
</cite> [<a href="https://doi.org/10.1186/s12920-016-0178-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4828881/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27067391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Medical%20Genomics&amp;title=A%20unified%20analytic%20framework%20for%20prioritization%20of%20non%E2%80%90coding%20variants%20of%20uncertain%20significance%20in%20heritable%20breast%20and%20ovarian%20cancer&amp;author=E.%20J.%20Mucaki&amp;author=N.%20G.%20Caminsky&amp;author=A.%20M.%20Perri&amp;author=R.%20Lu&amp;author=A.%20Laederach&amp;volume=9&amp;publication_year=2016&amp;pages=19&amp;pmid=27067391&amp;doi=10.1186/s12920-016-0178-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0035">
<cite>

Mueller, C. R.
, &amp; 
Roskelley, C. D.
 (2003). Regulation of BRCA1 expression and its relationship to sporadic breast cancer. Breast Cancer Research, 5(1), 45–52. 10.1186/bcr557
</cite> [<a href="https://doi.org/10.1186/bcr557" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC154136/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12559046/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Research&amp;title=Regulation%20of%20BRCA1%20expression%20and%20its%20relationship%20to%20sporadic%20breast%20cancer&amp;author=C.%20R.%20Mueller&amp;author=C.%20D.%20Roskelley&amp;volume=5&amp;issue=1&amp;publication_year=2003&amp;pages=45-52&amp;pmid=12559046&amp;doi=10.1186/bcr557&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0037">
<cite>

Peng, Y.
, &amp; 
Jahroudi, N.
 (2002). The NFY transcription factor functions as a repressor and activator of the von Willebrand factor promoter. Blood, 99(7), 2408–2417.</cite> [<a href="https://doi.org/10.1182/blood.v99.7.2408" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11895773/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=The%20NFY%20transcription%20factor%20functions%20as%20a%20repressor%20and%20activator%20of%20the%20von%20Willebrand%20factor%20promoter&amp;author=Y.%20Peng&amp;author=N.%20Jahroudi&amp;volume=99&amp;issue=7&amp;publication_year=2002&amp;pages=2408-2417&amp;pmid=11895773&amp;doi=10.1182/blood.v99.7.2408&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0038">
<cite>

Peng, Y.
, 
Stewart, D.
, 
Li, W.
, 
Hawkins, M.
, 
Kulak, S.
, 
Ballermann, B.
, &amp; 
Jahroudi, N.
 (2007). Irradiation modulates association of NF‐Y with histone‐modifying cofactors PCAF and HDAC. Oncogene, 26(54), 7576–7583. 10.1038/sj.onc.1210565
</cite> [<a href="https://doi.org/10.1038/sj.onc.1210565" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17599060/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Irradiation%20modulates%20association%20of%20NF%E2%80%90Y%20with%20histone%E2%80%90modifying%20cofactors%20PCAF%20and%20HDAC&amp;author=Y.%20Peng&amp;author=D.%20Stewart&amp;author=W.%20Li&amp;author=M.%20Hawkins&amp;author=S.%20Kulak&amp;volume=26&amp;issue=54&amp;publication_year=2007&amp;pages=7576-7583&amp;pmid=17599060&amp;doi=10.1038/sj.onc.1210565&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0039">
<cite>

Plon, S. E.
, 
Eccles, D. M.
, 
Easton, D.
, 
Foulkes, W. D.
, 
Genuardi, M.
, 
Greenblatt, M. S.
, … 
Group, I. U. G. V. W.
 (2008). Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat, 29(11), 1282–1291. 10.1002/humu.20880
</cite> [<a href="https://doi.org/10.1002/humu.20880" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3075918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18951446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=Sequence%20variant%20classification%20and%20reporting:%20recommendations%20for%20improving%20the%20interpretation%20of%20cancer%20susceptibility%20genetic%20test%20results&amp;author=S.%20E.%20Plon&amp;author=D.%20M.%20Eccles&amp;author=D.%20Easton&amp;author=W.%20D.%20Foulkes&amp;author=M.%20Genuardi&amp;volume=29&amp;issue=11&amp;publication_year=2008&amp;pages=1282-1291&amp;pmid=18951446&amp;doi=10.1002/humu.20880&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0040">
<cite>

Plon, S. E.
, 
Cooper, H. P.
, 
Parks, B.
, 
Dhar, S. U.
, 
Kelly, P. A.
, 
Weinberg, A. D.
, … 
Hilsenbeck, S.
 (2011). Genetic testing and cancer risk management recommendations by physicians for at‐risk relatives. Genetics in Medicine, 13(2), 148–154. 10.1097/GIM.0b013e318207f564
</cite> [<a href="https://doi.org/10.1097/GIM.0b013e318207f564" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3096073/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21224735/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genetics%20in%20Medicine&amp;title=Genetic%20testing%20and%20cancer%20risk%20management%20recommendations%20by%20physicians%20for%20at%E2%80%90risk%20relatives&amp;author=S.%20E.%20Plon&amp;author=H.%20P.%20Cooper&amp;author=B.%20Parks&amp;author=S.%20U.%20Dhar&amp;author=P.%20A.%20Kelly&amp;volume=13&amp;issue=2&amp;publication_year=2011&amp;pages=148-154&amp;pmid=21224735&amp;doi=10.1097/GIM.0b013e318207f564&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0041">
<cite>

Popanda, O.
, 
Seibold, P.
, 
Nikolov, I.
, 
Oakes, C. C.
, 
Burwinkel, B.
, 
Hausmann, S.
, … 
Schmezer, P.
 (2013). Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk. International Journal of Cancer, 132(1), 55–62. 10.1002/ijc.27665
</cite> [<a href="https://doi.org/10.1002/ijc.27665" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22684821/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Cancer&amp;title=Germline%20variants%20of%20base%20excision%20repair%20genes%20and%20breast%20cancer:%20A%20polymorphism%20in%20DNA%20polymerase%20gamma%20modifies%20gene%20expression%20and%20breast%20cancer%20risk&amp;author=O.%20Popanda&amp;author=P.%20Seibold&amp;author=I.%20Nikolov&amp;author=C.%20C.%20Oakes&amp;author=B.%20Burwinkel&amp;volume=132&amp;issue=1&amp;publication_year=2013&amp;pages=55-62&amp;pmid=22684821&amp;doi=10.1002/ijc.27665&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0042">
<cite>

Richards, S.
, 
Aziz, N.
, 
Bale, S.
, 
Bick, D.
, 
Das, S.
, 
Gastier‐Foster, J.
, … ACMG Laboratory Quality Assurance Committee
. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405–424. 10.1038/gim.2015.30
</cite> [<a href="https://doi.org/10.1038/gim.2015.30" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4544753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25741868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genetics%20in%20Medicine&amp;title=Standards%20and%20guidelines%20for%20the%20interpretation%20of%20sequence%20variants:%20A%20joint%20consensus%20recommendation%20of%20the%20American%20College%20of%20Medical%20Genetics%20and%20Genomics%20and%20the%20Association%20for%20Molecular%20Pathology&amp;author=S.%20Richards&amp;author=N.%20Aziz&amp;author=S.%20Bale&amp;author=D.%20Bick&amp;author=S.%20Das&amp;volume=17&amp;issue=5&amp;publication_year=2015&amp;pages=405-424&amp;pmid=25741868&amp;doi=10.1038/gim.2015.30&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0044">
<cite>

Santana dos Santos, E.
, 
Caputo, S. M.
, 
Castera, L.
, 
Gendrot, M.
, 
Briaux, A.
, 
Breault, M.
, … 
Rouleau, E.
 (2017). Assessment of the functional impact of germline BRCA1/2 variants located in non‐coding regions in families with breast and/or ovarian cancer predisposition. Breast Cancer Research and Treatment, 10.1007/s10549-017-4602-0
</cite> [<a href="https://doi.org/10.1007/s10549-017-4602-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29236234/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Research%20and%20Treatment&amp;title=Assessment%20of%20the%20functional%20impact%20of%20germline%20BRCA1/2%20variants%20located%20in%20non%E2%80%90coding%20regions%20in%20families%20with%20breast%20and/or%20ovarian%20cancer%20predisposition&amp;author=E.%20Santana%20dos%20Santos&amp;author=S.%20M.%20Caputo&amp;author=L.%20Castera&amp;author=M.%20Gendrot&amp;author=A.%20Briaux&amp;publication_year=2017&amp;pmid=29236234&amp;doi=10.1007/s10549-017-4602-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0045">
<cite>

Saunus, J. M.
, 
French, J. D.
, 
Edwards, S. L.
, 
Beveridge, D. J.
, 
Hatchell, E. C.
, 
Wagner, S. A.
, … 
Brown, M. A.
 (2008). Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR. Cancer Research, 68(22), 9469–9478. 10.1158/0008-5472.CAN-08-1159
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-08-1159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19010922/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Research&amp;title=Posttranscriptional%20regulation%20of%20the%20breast%20cancer%20susceptibility%20gene%20BRCA1%20by%20the%20RNA%20binding%20protein%20HuR&amp;author=J.%20M.%20Saunus&amp;author=J.%20D.%20French&amp;author=S.%20L.%20Edwards&amp;author=D.%20J.%20Beveridge&amp;author=E.%20C.%20Hatchell&amp;volume=68&amp;issue=22&amp;publication_year=2008&amp;pages=9469-9478&amp;pmid=19010922&amp;doi=10.1158/0008-5472.CAN-08-1159&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0046">
<cite>

Sawyer, S.
, 
Mitchell, G.
, 
McKinley, J.
, 
Chenevix‐Trench, G.
, 
Beesley, J.
, 
Chen, X. Q.
, … 
James, P. A.
 (2012). A role for common genomic variants in the assessment of familial breast cancer. Journal of Clinical Oncology, 30(35), 4330–4336. 10.1200/JCO.2012.41.7469
</cite> [<a href="https://doi.org/10.1200/JCO.2012.41.7469" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23109704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Oncology&amp;title=A%20role%20for%20common%20genomic%20variants%20in%20the%20assessment%20of%20familial%20breast%20cancer&amp;author=S.%20Sawyer&amp;author=G.%20Mitchell&amp;author=J.%20McKinley&amp;author=G.%20Chenevix%E2%80%90Trench&amp;author=J.%20Beesley&amp;volume=30&amp;issue=35&amp;publication_year=2012&amp;pages=4330-4336&amp;pmid=23109704&amp;doi=10.1200/JCO.2012.41.7469&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0047">
<cite>

Shimelis, H.
, 
Mesman, R. L. S.
, 
Von Nicolai, C.
, 
Ehlen, A.
, 
Guidugli, L.
, &amp; 
Martin, C.
, … for, N. C
. (2017). BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Research, 77(11), 2789–2799. 10.1158/0008-5472.CAN-16-2568
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-16-2568" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5508554/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28283652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Research&amp;title=BRCA2%20hypomorphic%20missense%20variants%20confer%20moderate%20risks%20of%20breast%20cancer&amp;author=H.%20Shimelis&amp;author=R.%20L.%20S.%20Mesman&amp;author=C.%20Von%20Nicolai&amp;author=A.%20Ehlen&amp;author=L.%20Guidugli&amp;volume=77&amp;issue=11&amp;publication_year=2017&amp;pages=2789-2799&amp;pmid=28283652&amp;doi=10.1158/0008-5472.CAN-16-2568&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0048">
<cite>

Skol, A. D.
, 
Sasaki, M. M.
, &amp; 
Onel, K.
 (2016). The genetics of breast cancer risk in the post‐genome era: Thoughts on study design to move past BRCA and towards clinical relevance. Breast Cancer Research, 18(1), 99
10.1186/s13058-016-0759-4
</cite> [<a href="https://doi.org/10.1186/s13058-016-0759-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5048663/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27716388/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Research&amp;title=The%20genetics%20of%20breast%20cancer%20risk%20in%20the%20post%E2%80%90genome%20era:%20Thoughts%20on%20study%20design%20to%20move%20past%20BRCA%20and%20towards%20clinical%20relevance&amp;author=A.%20D.%20Skol&amp;author=M.%20M.%20Sasaki&amp;author=K.%20Onel&amp;volume=18&amp;issue=1&amp;publication_year=2016&amp;pages=99&amp;pmid=27716388&amp;doi=10.1186/s13058-016-0759-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0049">
<cite>

Soukupova, J.
, 
Zemankova, P.
, 
Kleiblova, P.
, 
Janatova, M.
, &amp; 
Kleibl, Z.
 (2016). [CZECANCA: CZEch CAncer paNel for clinical application— Design and optimization of the targeted sequencing panel for the identification of cancer susceptibility in high‐risk individuals from the Czech Republic]. Klinická Onkologie, 29, (Suppl 1), S46–54. 10.14735/amko2016S46
</cite> [<a href="https://doi.org/10.14735/amko2016S46" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26691942/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Klinick%C3%A1%20Onkologie&amp;title=%5BCZECANCA:%20CZEch%20CAncer%20paNel%20for%20clinical%20application%E2%80%94%20Design%20and%20optimization%20of%20the%20targeted%20sequencing%20panel%20for%20the%20identification%20of%20cancer%20susceptibility%20in%20high%E2%80%90risk%20individuals%20from%20the%20Czech%20Republic%5D&amp;author=J.%20Soukupova&amp;author=P.%20Zemankova&amp;author=P.%20Kleiblova&amp;author=M.%20Janatova&amp;author=Z.%20Kleibl&amp;volume=29&amp;issue=Suppl%201&amp;publication_year=2016&amp;pages=S46-54&amp;pmid=26691942&amp;doi=10.14735/amko2016S46&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0050">
<cite>

Spurdle, A. B.
, 
Whiley, P. J.
, 
Thompson, B.
, 
Feng, B.
, 
Healey, S.
, 
Brown, M. A.
, … 
Consortium, E.
 (2012). BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk. Journal of Medical Genetics, 49(8), 525–532. 10.1136/jmedgenet-2012-101037
</cite> [<a href="https://doi.org/10.1136/jmedgenet-2012-101037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3810416/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22889855/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Medical%20Genetics&amp;title=BRCA1%20R1699Q%20variant%20displaying%20ambiguous%20functional%20abrogation%20confers%20intermediate%20breast%20and%20ovarian%20cancer%20risk&amp;author=A.%20B.%20Spurdle&amp;author=P.%20J.%20Whiley&amp;author=B.%20Thompson&amp;author=B.%20Feng&amp;author=S.%20Healey&amp;volume=49&amp;issue=8&amp;publication_year=2012&amp;pages=525-532&amp;pmid=22889855&amp;doi=10.1136/jmedgenet-2012-101037&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0051">
<cite>

Stranger, B. E.
, 
Forrest, M. S.
, 
Clark, A. G.
, 
Minichiello, M. J.
, 
Deutsch, S.
, 
Lyle, R.
, … 
Dermitzakis, E. T.
 (2005). Genome‐wide associations of gene expression variation in humans. PLoS Genetics, 1(6), e78
10.1371/journal.pgen.0010078
</cite> [<a href="https://doi.org/10.1371/journal.pgen.0010078" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1315281/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16362079/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Genetics&amp;title=Genome%E2%80%90wide%20associations%20of%20gene%20expression%20variation%20in%20humans&amp;author=B.%20E.%20Stranger&amp;author=M.%20S.%20Forrest&amp;author=A.%20G.%20Clark&amp;author=M.%20J.%20Minichiello&amp;author=S.%20Deutsch&amp;volume=1&amp;issue=6&amp;publication_year=2005&amp;pages=e78&amp;pmid=16362079&amp;doi=10.1371/journal.pgen.0010078&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0052">
<cite>

Stranger, B. E.
, 
Nica, A. C.
, 
Forrest, M. S.
, 
Dimas, A.
, 
Bird, C. P.
, 
Beazley, C.
, … 
Dermitzakis, E. T.
 (2007). Population genomics of human gene expression. Nature Genetics, 39(10), 1217–1224. 10.1038/ng2142
</cite> [<a href="https://doi.org/10.1038/ng2142" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2683249/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17873874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Genetics&amp;title=Population%20genomics%20of%20human%20gene%20expression&amp;author=B.%20E.%20Stranger&amp;author=A.%20C.%20Nica&amp;author=M.%20S.%20Forrest&amp;author=A.%20Dimas&amp;author=C.%20P.%20Bird&amp;volume=39&amp;issue=10&amp;publication_year=2007&amp;pages=1217-1224&amp;pmid=17873874&amp;doi=10.1038/ng2142&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0053">
<cite>

Suen, T. C.
, &amp; 
Goss, P. E.
 (1999). Transcription of BRCA1 is dependent on the formation of a specific protein‐DNA complex on the minimal BRCA1 Bi‐directional promoter. Journal of Biological Chemistry, 274(44), 31297–31304.</cite> [<a href="https://doi.org/10.1074/jbc.274.44.31297" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10531328/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biological%20Chemistry&amp;title=Transcription%20of%20BRCA1%20is%20dependent%20on%20the%20formation%20of%20a%20specific%20protein%E2%80%90DNA%20complex%20on%20the%20minimal%20BRCA1%20Bi%E2%80%90directional%20promoter&amp;author=T.%20C.%20Suen&amp;author=P.%20E.%20Goss&amp;volume=274&amp;issue=44&amp;publication_year=1999&amp;pages=31297-31304&amp;pmid=10531328&amp;doi=10.1074/jbc.274.44.31297&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0054">
<cite>

Tan‐Wong, S. M.
, 
French, J. D.
, 
Proudfoot, N. J.
, &amp; 
Brown, M. A.
 (2008). Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene. Proceedings of the National Academy of Sciences of the United States of America, 105(13), 5160–5165. 10.1073/pnas.0801048105
</cite> [<a href="https://doi.org/10.1073/pnas.0801048105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2278189/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18375767/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20of%20the%20United%20States%20of%20America&amp;title=Dynamic%20interactions%20between%20the%20promoter%20and%20terminator%20regions%20of%20the%20mammalian%20BRCA1%20gene&amp;author=S.%20M.%20Tan%E2%80%90Wong&amp;author=J.%20D.%20French&amp;author=N.%20J.%20Proudfoot&amp;author=M.%20A.%20Brown&amp;volume=105&amp;issue=13&amp;publication_year=2008&amp;pages=5160-5165&amp;pmid=18375767&amp;doi=10.1073/pnas.0801048105&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0055">
<cite>

Thakur, S.
, &amp; 
Croce, C. M.
 (1999). Positive regulation of the BRCA1 promoter. Journal of Biological Chemistry, 274(13), 8837–8843.</cite> [<a href="https://doi.org/10.1074/jbc.274.13.8837" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10085126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biological%20Chemistry&amp;title=Positive%20regulation%20of%20the%20BRCA1%20promoter&amp;author=S.%20Thakur&amp;author=C.%20M.%20Croce&amp;volume=274&amp;issue=13&amp;publication_year=1999&amp;pages=8837-8843&amp;pmid=10085126&amp;doi=10.1074/jbc.274.13.8837&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0056">
<cite>

Tran, D. H.
, 
Shishido, Y.
, 
Chung, S. P.
, 
Trinh, H. T.
, 
Yorita, K.
, 
Sakai, T.
, &amp; 
Fukui, K.
 (2015). Identification of two promoters for human D‐amino acid oxidase gene: Implication for the differential promoter regulation mediated by PAX5/PAX2. Journal of Biochemistry, 157(5), 377–387. 10.1093/jb/mvu084
</cite> [<a href="https://doi.org/10.1093/jb/mvu084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25500505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biochemistry&amp;title=Identification%20of%20two%20promoters%20for%20human%20D%E2%80%90amino%20acid%20oxidase%20gene:%20Implication%20for%20the%20differential%20promoter%20regulation%20mediated%20by%20PAX5/PAX2&amp;author=D.%20H.%20Tran&amp;author=Y.%20Shishido&amp;author=S.%20P.%20Chung&amp;author=H.%20T.%20Trinh&amp;author=K.%20Yorita&amp;volume=157&amp;issue=5&amp;publication_year=2015&amp;pages=377-387&amp;pmid=25500505&amp;doi=10.1093/jb/mvu084&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0063">
<cite>

Vallee, M. P.
, 
Di Sera, T. L.
, 
Nix, D. A.
, 
Paquette, A. M.
, 
Parsons, M. T.
, 
Bell, R.
, … 
Tavtigian, S. V.
 (2016). Adding In Silico Assessment of Potential Splice Aberration to the Integrated Evaluation of BRCA Gene Unclassified Variants. Hum Mutat, 37(7), 627–639. 10.1002/humu.22973
</cite> [<a href="https://doi.org/10.1002/humu.22973" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4907813/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26913838/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=Adding%20In%20Silico%20Assessment%20of%20Potential%20Splice%20Aberration%20to%20the%20Integrated%20Evaluation%20of%20BRCA%20Gene%20Unclassified%20Variants&amp;author=M.%20P.%20Vallee&amp;author=T.%20L.%20Di%20Sera&amp;author=D.%20A.%20Nix&amp;author=A.%20M.%20Paquette&amp;author=M.%20T.%20Parsons&amp;volume=37&amp;issue=7&amp;publication_year=2016&amp;pages=627-639&amp;pmid=26913838&amp;doi=10.1002/humu.22973&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0057">
<cite>

Walsh, T.
, 
Casadei, S.
, 
Coats, K. H.
, 
Swisher, E.
, 
Stray, S. M.
, 
Higgins, J.
, … 
King, M. C.
 (2006). Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA, 295(12), 1379–1388. 10.1001/jama.295.12.1379
</cite> [<a href="https://doi.org/10.1001/jama.295.12.1379" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16551709/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Spectrum%20of%20mutations%20in%20BRCA1,%20BRCA2,%20CHEK2,%20and%20TP53%20in%20families%20at%20high%20risk%20of%20breast%20cancer&amp;author=T.%20Walsh&amp;author=S.%20Casadei&amp;author=K.%20H.%20Coats&amp;author=E.%20Swisher&amp;author=S.%20M.%20Stray&amp;volume=295&amp;issue=12&amp;publication_year=2006&amp;pages=1379-1388&amp;pmid=16551709&amp;doi=10.1001/jama.295.12.1379&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0058">
<cite>

Wardrop, S. L.
, 
Brown, M. A.
, &amp; 
kConFab, I.
 (2005). Identification of two evolutionarily conserved and functional regulatory elements in intron 2 of the human BRCA1 gene. Genomics, 86(3), 316–328. 10.1016/j.ygeno.2005.05.006
</cite> [<a href="https://doi.org/10.1016/j.ygeno.2005.05.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15990270/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genomics&amp;title=Identification%20of%20two%20evolutionarily%20conserved%20and%20functional%20regulatory%20elements%20in%20intron%202%20of%20the%20human%20BRCA1%20gene&amp;author=S.%20L.%20Wardrop&amp;author=M.%20A.%20Brown&amp;author=I.%20kConFab&amp;volume=86&amp;issue=3&amp;publication_year=2005&amp;pages=316-328&amp;pmid=15990270&amp;doi=10.1016/j.ygeno.2005.05.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0059">
<cite>

Wiedemeyer, W. R.
, 
Beach, J. A.
, &amp; 
Karlan, B. Y.
 (2014). Reversing platinum resistance in high‐grade serous ovarian carcinoma: Targeting BRCA and the homologous recombination system. Frontiers in Oncology, 4, 34
10.3389/fonc.2014.00034
</cite> [<a href="https://doi.org/10.3389/fonc.2014.00034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3939430/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24624361/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Oncology&amp;title=Reversing%20platinum%20resistance%20in%20high%E2%80%90grade%20serous%20ovarian%20carcinoma:%20Targeting%20BRCA%20and%20the%20homologous%20recombination%20system&amp;author=W.%20R.%20Wiedemeyer&amp;author=J.%20A.%20Beach&amp;author=B.%20Y.%20Karlan&amp;volume=4&amp;publication_year=2014&amp;pages=34&amp;pmid=24624361&amp;doi=10.3389/fonc.2014.00034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0060">
<cite>

Xu, C. F.
, 
Chambers, J. A.
, &amp; 
Solomon, E.
 (1997). Complex regulation of the BRCA1 gene. Journal of Biological Chemistry, 272(34), 20994–20997. 10.1074/jbc.272.34.20994
</cite> [<a href="https://doi.org/10.1074/jbc.272.34.20994" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9261099/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biological%20Chemistry&amp;title=Complex%20regulation%20of%20the%20BRCA1%20gene&amp;author=C.%20F.%20Xu&amp;author=J.%20A.%20Chambers&amp;author=E.%20Solomon&amp;volume=272&amp;issue=34&amp;publication_year=1997&amp;pages=20994-20997&amp;pmid=9261099&amp;doi=10.1074/jbc.272.34.20994&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="humu23652-bib-0061">
<cite>

Zhu, X.
, 
Wang, Y.
, 
Pi, W.
, 
Liu, H.
, 
Wickrema, A.
, &amp; 
Tuan, D.
 (2012). NF‐Y recruits both transcription activator and repressor to modulate tissue‐ and developmental stage‐specific expression of human gamma‐globin gene. PLoS One, 7(10), e47175
10.1371/journal.pone.0047175
</cite> [<a href="https://doi.org/10.1371/journal.pone.0047175" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3468502/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23071749/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=NF%E2%80%90Y%20recruits%20both%20transcription%20activator%20and%20repressor%20to%20modulate%20tissue%E2%80%90%20and%20developmental%20stage%E2%80%90specific%20expression%20of%20human%20gamma%E2%80%90globin%20gene&amp;author=X.%20Zhu&amp;author=Y.%20Wang&amp;author=W.%20Pi&amp;author=H.%20Liu&amp;author=A.%20Wickrema&amp;volume=7&amp;issue=10&amp;publication_year=2012&amp;pages=e47175&amp;pmid=23071749&amp;doi=10.1371/journal.pone.0047175&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<p>Supplementary Figure S1. Variants in <em>BRCA1</em> and <em>BRCA2</em> overlap with potential TF binding sites. Snapshots of the UCSC genome browser showing <em>BRCA1</em> (A) and <em>BRCA2</em> (B) prioritized variants and ENCODE ChIP‐seq data from multiple cell lines and available breast cell specific TF ChIPseq data. TF consensus motifs within the ENCODE ChIP‐seq dataset tracks are displayed in green. Genomic position of variants that alter luciferase activity are indicated by vertical lines.</p>
<p>Supplementary Table S1. Oligonucleotides used in this study</p>
<p>Supplementary Table S2. Overview of rare variants in the <em>BRCA1</em> 5'upstream region in patients and controls.*</p>
<p>Supplementary Table S3. Overview of rare variants in the <em>BRCA2</em> 5'upstream region in patients and controls.*</p>
<p>Supplementary Table S4. Information Theory Analysis of Prioritized Variants</p>
<p>Supplementary Table S5. Clinical classification of <em>BRCA1</em> and <em>BRCA2</em> 5' noncoding variants</p>
<p>Supplementary Table S6. Tumour histopathology status for <em>BRCA1</em> and <em>BRCA2</em> 5' noncoding variants</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/6282814/bin/HUMU-39-2025-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (606.9KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><p>Supplementary methods</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/6282814/bin/HUMU-39-2025-s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (101.6KB, pdf) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Human Mutation are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1002/humu.23652"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/HUMU-39-2025.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.0 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/6282814/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/6282814/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC6282814%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC6282814/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC6282814/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC6282814/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/30204945/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC6282814/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/30204945/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC6282814/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/6282814/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="8cnDWi1xd2Oh8aVSGhu7R3WtXXtjTa3yKmNQIau5uKiBjgqTWgSHobP94PSwWVy3">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
